
<html lang="en"     class="pb-page"  data-request-id="cfe9969f-53dc-45f9-8fa0-1bce80f2015e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-6;page:string:Article/Chapter View;article:article:10.1021/jm401982j;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Using Ovality to Predict Nonmutagenic, Orally Efficacious Pyridazine Amides as Cell Specific Spleen Tyrosine Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Matthew C.  Lucas" /></meta><meta name="dc.Creator" content="Niala  Bhagirath" /></meta><meta name="dc.Creator" content="Eric  Chiao" /></meta><meta name="dc.Creator" content="David M.  Goldstein" /></meta><meta name="dc.Creator" content="Johannes C.  Hermann" /></meta><meta name="dc.Creator" content="Pei-Yuan  Hsu" /></meta><meta name="dc.Creator" content="Stephan  Kirchner" /></meta><meta name="dc.Creator" content="Joshua J.  Kennedy-Smith" /></meta><meta name="dc.Creator" content="Andreas  Kuglstatter" /></meta><meta name="dc.Creator" content="Christine  Lukacs" /></meta><meta name="dc.Creator" content="John  Menke" /></meta><meta name="dc.Creator" content="Linghao  Niu" /></meta><meta name="dc.Creator" content="Fernando  Padilla" /></meta><meta name="dc.Creator" content="Ying  Peng" /></meta><meta name="dc.Creator" content="Liudmila  Polonchuk" /></meta><meta name="dc.Creator" content="Aruna  Railkar" /></meta><meta name="dc.Creator" content="Michelle  Slade" /></meta><meta name="dc.Creator" content="Michael  Soth" /></meta><meta name="dc.Creator" content="Daigen  Xu" /></meta><meta name="dc.Creator" content="Preeti  Yadava" /></meta><meta name="dc.Creator" content="Calvin  Yee" /></meta><meta name="dc.Creator" content="Mingyan  Zhou" /></meta><meta name="dc.Creator" content="Cheng  Liao" /></meta><meta name="dc.Description" content="Inhibition of spleen tyrosine kinase has attracted much attention as a mechanism for the treatment of cancers and autoimmune diseases such as asthma, rheumatoid arthritis, and systemic lupus erythe..." /></meta><meta name="Description" content="Inhibition of spleen tyrosine kinase has attracted much attention as a mechanism for the treatment of cancers and autoimmune diseases such as asthma, rheumatoid arthritis, and systemic lupus erythe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 26, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401982j" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401982j" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401982j" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401982j" /></link>
        
    
    

<title>Using Ovality to Predict Nonmutagenic, Orally Efficacious Pyridazine Amides as Cell Specific Spleen Tyrosine Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401982j" /></meta><meta property="og:title" content="Using Ovality to Predict Nonmutagenic, Orally Efficacious Pyridazine Amides as Cell Specific Spleen Tyrosine Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0015.jpeg" /></meta><meta property="og:description" content="Inhibition of spleen tyrosine kinase has attracted much attention as a mechanism for the treatment of cancers and autoimmune diseases such as asthma, rheumatoid arthritis, and systemic lupus erythematous. We report the structure-guided optimization of pyridazine amide spleen tyrosine kinase inhibitors. Early representatives of this scaffold were highly potent and selective but mutagenic in an Ames assay. An approach that led to the successful identification of nonmutagenic examples, as well as further optimization to compounds with reduced cardiovascular liabilities is described. Select pharmacokinetic and in vivo efficacy data are presented." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401982j"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401982j">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401982j&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401982j&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401982j&amp;href=/doi/10.1021/jm401982j" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2683-2691</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401958n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500007h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Using Ovality to Predict Nonmutagenic, Orally Efficacious Pyridazine Amides as Cell Specific Spleen Tyrosine Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+C.++Lucas">Matthew C. Lucas</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niala++Bhagirath">Niala Bhagirath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Chiao">Eric Chiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Goldstein">David M. Goldstein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johannes+C.++Hermann">Johannes C. Hermann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pei-Yuan++Hsu">Pei-Yuan Hsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephan++Kirchner">Stephan Kirchner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua+J.++Kennedy-Smith">Joshua J. Kennedy-Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Kuglstatter">Andreas Kuglstatter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Lukacs">Christine Lukacs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Menke">John Menke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linghao++Niu">Linghao Niu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Padilla">Fernando Padilla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Peng">Ying Peng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liudmila++Polonchuk">Liudmila Polonchuk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aruna++Railkar">Aruna Railkar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Slade">Michelle Slade</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Soth">Michael Soth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daigen++Xu">Daigen Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Preeti++Yadava">Preeti Yadava</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Calvin++Yee">Calvin Yee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mingyan++Zhou">Mingyan Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Liao">Cheng Liao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecule Research, Grenzacherstrasse 124, 4070 Basle, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-408-585-8051; e-mail: <a href="/cdn-cgi/l/email-protection#15787461617d70623b7960767466557660777c66613b767a78"><span class="__cf_email__" data-cfemail="a7cac6d3d3cfc2d089cbd2c4c6d4e7c4d2c5ced4d389c4c8ca">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401982j&amp;href=/doi/10.1021%2Fjm401982j" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2683â2691</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 12, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 December 2013</li><li><span class="item_label"><b>Published</b> online</span>26 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401982j" title="DOI URL">https://doi.org/10.1021/jm401982j</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2683%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BC.%2BLucas%252C%2BNiala%2BBhagirath%252C%2BEric%2BChiao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D6%26contentID%3Djm401982j%26title%3DUsing%2BOvality%2Bto%2BPredict%2BNonmutagenic%252C%2BOrally%2BEfficacious%2BPyridazine%2BAmides%2Bas%2BCell%2BSpecific%2BSpleen%2BTyrosine%2BKinase%2BInhibitors%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2691%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401982j"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2345</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401982j" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Using Ovality to Predict Nonmutagenic, Orally Efficacious Pyridazine Amides as Cell Specific Spleen Tyrosine Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;C. Lucas&quot;},{&quot;first_name&quot;:&quot;Niala&quot;,&quot;last_name&quot;:&quot;Bhagirath&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Chiao&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Goldstein&quot;},{&quot;first_name&quot;:&quot;Johannes&quot;,&quot;last_name&quot;:&quot;C. Hermann&quot;},{&quot;first_name&quot;:&quot;Pei-Yuan&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Stephan&quot;,&quot;last_name&quot;:&quot;Kirchner&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;J. Kennedy-Smith&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Kuglstatter&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Lukacs&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Menke&quot;},{&quot;first_name&quot;:&quot;Linghao&quot;,&quot;last_name&quot;:&quot;Niu&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Padilla&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Liudmila&quot;,&quot;last_name&quot;:&quot;Polonchuk&quot;},{&quot;first_name&quot;:&quot;Aruna&quot;,&quot;last_name&quot;:&quot;Railkar&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Slade&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Soth&quot;},{&quot;first_name&quot;:&quot;Daigen&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Preeti&quot;,&quot;last_name&quot;:&quot;Yadava&quot;},{&quot;first_name&quot;:&quot;Calvin&quot;,&quot;last_name&quot;:&quot;Yee&quot;},{&quot;first_name&quot;:&quot;Mingyan&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Liao&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;2683-2691&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401982j&quot;},&quot;abstract&quot;:&quot;Inhibition of spleen tyrosine kinase has attracted much attention as a mechanism for the treatment of cancers and autoimmune diseases such as asthma, rheumatoid arthritis, and systemic lupus erythematous. We report the structure-guided optimization of pyridazine amide spleen tyrosine kinase inhibitors. Early representatives of this scaffold were highly potent and selective but mutagenic in an Ames assay. An approach that led to the successful identification of nonmutagenic examples, as well as further optimization to compounds with reduced cardiovascular liabilities is described. Select pharmacokinetic and in vivo efficacy data are presented.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401982j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401982j" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401982j&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401982j" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401982j&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401982j" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401982j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401982j&amp;href=/doi/10.1021/jm401982j" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401982j" /></input><a href="/doi/pdf/10.1021/jm401982j" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401982j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401982j%26sid%3Dliteratum%253Aachs%26pmid%3D24520947%26genre%3Darticle%26aulast%3DLucas%26date%3D2014%26atitle%3DUsing%2BOvality%2Bto%2BPredict%2BNonmutagenic%252C%2BOrally%2BEfficacious%2BPyridazine%2BAmides%2Bas%2BCell%2BSpecific%2BSpleen%2BTyrosine%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D6%26spage%3D2683%26epage%3D2691%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jmcmar.2014.57.issue-6/production/jmcmar.2014.57.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of spleen tyrosine kinase has attracted much attention as a mechanism for the treatment of cancers and autoimmune diseases such as asthma, rheumatoid arthritis, and systemic lupus erythematous. We report the structure-guided optimization of pyridazine amide spleen tyrosine kinase inhibitors. Early representatives of this scaffold were highly potent and selective but mutagenic in an Ames assay. An approach that led to the successful identification of nonmutagenic examples, as well as further optimization to compounds with reduced cardiovascular liabilities is described. Select pharmacokinetic and in vivo efficacy data are presented.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Spleen tyrosine kinase (Syk) is an intracellular protein tyrosine kinase whose signaling pathway is largely involved in the adaptive immune response but also in some innate and nonimmune functions.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Syk is most widely expressed in hematopoietic cells but is also expressed in other tissues. It serves as a key mediator of B-cell receptor- and Fc receptor-mediated signaling in inflammatory cells such as B-cells, mast cells, macrophages, dendritic cells, and neutrophils, and it is involved in bone resorption by osteoclasts.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> The activation of Syk leads to a variety of downstream events including cytokine release, differentiation, proliferation, reactive oxygen species (ROS) production, cytoskeletal rearrangement, and cell survival. Fostamatinib (<b>1</b>), a poorly selective Syk inhibitor (vide infra), recently completed phase II trials for the treatment of rheumatoid arthritis but subsequently failed in phase III.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> PRT-062607 (<b>2</b>)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> a somewhat more selective diaminopyrimidine derivative, recently completed phase I clinical trials and is currently in phase II for allergic asthma and other inflammatory disorders. Trials in Lupus as well as various oncology indications are also planned or likely (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The entry of GS-9973 into phase I for the treatment for rheumatoid arthritis was reported, although this indication is no longer included on the company pipeline slide.  The drug is currently in phase II with Hematological Malignancies listed as a potential indication.  It is being developed both as a single agent as well as in combination with Idelalisib, a PI3K delta inhibitor.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> GSK-143 (<b>3</b>) is reported to be a highly selective and potent Syk inhibitor and belongs to the same pyrimidine scaffold as <b>2</b>, although this compound did not advance to the clinic due to mutagenicity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Fostamatinib (<b>1</b>), PRT-062607 (<b>2</b>), and GSK-143 (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> is not selective for Syk versus other kinase enzymes.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It has been reported that the off-target inhibition of VEGFR2 may have been responsible for the hypertension observed in patients receiving the drug in clinical trials.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Portola and GlaxoSmithKline report that <b>2</b> and <b>3</b> each show improved selectivity and have presented some data that support these statements.<a onclick="showRef(event, 'ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref8">(6, 8)</a> Previously, we described a hypothesis describing how highly selective Syk inhibitors can be designed by targeting specific residues in and around the Syk active site that appear only rarely among other kinases (Pro455 and Asn457, or Pro455 alone).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> We have since disclosed additional scaffolds that lend support to this hypothesis (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <b>4</b>â<b>8</b>).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of Roche selective Syk inhibitors <b>4</b>â<b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">One of the challenges encountered in our earlier efforts was pairing exceptionally high selectivity with good pharmacokinetic (PK) properties. Herein, we describe the structureâactivity relationship (SAR) of a series of diaminopyridazine amides (e.g., <b>8</b>â<b>9</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) that combine a binding interaction with Pro455 to deliver the requisite selectivity, with exceptional biopharmaceutical properties to convey high in vivo efficacy in a mouse model of rheumatoid arthritis. To the best of our knowledge, these represent the most selective and potent Syk inhibitors reported to date. As also reported by the GSK group for <b>3</b>, we observed mutagenicity in an expanded Salmonella mutagenicity test panel that included the Ames TA1537 salmonella strain.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Mutagenicity was unexpected based on in silico predictions. We provide our hypothesis for the cause of the observed mutagenicity and how this led us to identify nonmutagenic molecules. The ensuing optimization process and delivery of candidate molecules possessing high potency, high selectivity, and acceptable safety windows will be illustrated.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have previously reported the crystal structures of several inhibitors bound to Syk.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We determined that compounds such as <b>2</b> bind in the Syk pocket with the aniline moiety positioned above Gly454/Pro455 and that the diamino groups occupy the ribose pocket of the ATP binding site. It is reasonable to expect that <b>2</b> and <b>3</b> form similar interactions with the protein. High levels of selectivity have been claimed for these compounds. Our experience building Syk selectivity into other chemical scaffolds (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) led us to contemplate that, if the interaction with Pro455 could be enhanced further, selectivity might also be superior. We felt that selective Syk inhibitors would provide critical differentiation from the competition by reducing the risk of off-target toxicities that have been observed, for example, with <b>1</b> and any that emerge during the phase II clinical trial of <b>2</b>. We designed a pyridazine carboxamide scaffold (<b>13</b>, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) in which intramolecular hydrogen bonding between the pyridazine core and a 2-aminopyridine would favor one conformation and facilitate exploration and optimization of hydrophobic interactions with Pro455. An added advantage, we hoped, was that that we would have also replaced a potentially problematic aniline group in pyrimidines <b>1</b>â<b>3</b> with a safer 2-aminopyridine fragment.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyridazines <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) 2-aminopyridine, acetonitrile, 80 Â°C; (b) 7 N ammonia in methanol, rt; (c) R<sup>3</sup>-NH<sub>2</sub>, NMP, 140 Â°C.</p></p></figure><div class="NLM_p">No pyridazines of this type were known in the literature, but fortunately, we were able to synthesize our compounds based on a three to four step procedure starting from commercially available pyridazine <b>10</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Regioselective nucleophilic displacement of chlorine with the appropriate 2-aminopyridine under thermal conditions gave <b>11</b>. Simply stirring the resulting ester in methanolic ammonia provided primary amide <b>12</b>. A second nucleophilic displacement with an alkylamine followed by a Boc deprotection then gives the final product <b>13</b> (in some cases where a protecting group was not present, the final product was obtained directly from the nucleophilic displacement).</div><div class="NLM_p">Our prototype compound <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was a potent Syk inhibitor and selective in a small panel of 30 kinases that sampled all of the kinase families.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> When tested at 1 Î¼M, only Syk was inhibited greater than 90% (i.e., 1/30 kinases greater than 90% at 1 Î¼M). We are satisfied that this small 30 kinase panel is an accurate predictor of selectivity based on results of compounds tested previously in a larger, traditional kinase binding assay panel and used by us previously.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> For example, <b>19</b> inhibited 2/30 kinases greater than 90% in our small panel (Syk and PDGFRÎ²) and 6/392 kinases greater than 90% in a larger panel. As well as assessing the biochemical selectivity of our Syk inhibitors in the 30 kinase panel, we determined a cell-based selectivity ratio. This was based on the on-target effect of inhibitors of Î±-IgM antibody-mediated intracellular calcium increase in human Ramos B cells versus the off-target effect of T cell receptor induced calcium influx in human Jurkat T cells. We set ourselves a goal of achieving good biochemical selectivity as well as at least a 10-fold selectivity ratio in the cell-based assays. The cell-based selectivity ratio for <b>9</b> was 9-fold. We were very encouraged by this intitial selectivity data as this represented the smallest substituent expected to interact with Pro455, and it compared very favorably to our benchmark Syk inhibitors. We used Fostamatinib (<b>1</b>) and PRT-062607 (<b>2</b>) as our benchmarks, since these were the most advanced Syk inhibitors currently progressing in clinical trials. Compound <b>1</b> inhibited 6/30 kinases greater than 90% at 1 Î¼M and had a cell-based selectivity ratio of 0.5. Compound <b>2</b> was somewhat more selective and inhibited 4/30 kinases greater than 90% at 1 Î¼M and had a cell-based selectivity ratio of 0.8.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Syk Activity, Selectivity, Human Whole Blood Potency, and hERG Channel Inhibition by Pyridazine Amides <b>9</b> and <b>14</b>â<b>23</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">Syk pIC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">selectivity<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (no. kinase inhibited >90% at 1 Î¼M)</th><th class="colsep0 rowsep0" align="center">T cell/B cell selectivity ratio<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HWB pIC<sub>50</sub><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">hERG pIC<sub>50</sub><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">âCH<sub>2</sub>â</td><td class="colsep0 rowsep0" align="left">âCH<sub>2</sub>â</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">5.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">See Experimental Section (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) for details.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Carna Bioscience Inc. screening platform measurements employing an enzyme binding assay to quantitatively measure interactions between test compounds at 1 Î¼M and a panel of 30 kinases.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Ratio of Jurkat T cell IC<sub>50</sub> divided by Ramos B cell IC<sub>50</sub>.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Human whole blood pIC<sub>50</sub>.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">hERG channel pIC<sub>50</sub>.</p></div></div></div><div class="NLM_p">We anticipated some potential hERG binding due to the basic amine, but we hoped that the low clogP and high PSA would reduce the propensity to bind and provide sufficient therapeutic windows. Our goal was to achieve a greater than 30-fold window between the human whole blood IC<sub>50</sub> and the hERG IC<sub>50</sub> corrected for protein binding. Compound <b>9</b> easily met this criterion, displaying a 126-fold window. Thus, while it remained important that we monitored hERG closely, it did not prohibit us from examining the series further.</div><div class="NLM_p">Further profiling of <b>9</b> showed promising biopharmaceutical properties; it was soluble, and despite a low predicted permeability and high polar surface area, it was highly permeable when measured in a CACO2 permeability assay and potent in our cell assay (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>â<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). We rationalized that the good permeability was due to the effective masking of some of the donor and acceptor atoms through intramolecular hydrogen-bond formation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The in vitro profile translated into good rat in vivo PK (unpublished results). This was of critical importance to us, since achieving suitable PK profiles had been a challenge in some of our earlier scaffolds.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Solubility<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>, Permeability<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a>, Human Plasma Protein Binding<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a>, CYP450 Inhibition<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a>, and Liver Microsomal Stability<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a><a class="ref internalNav" href="#t2fn7" aria-label="g">g</a> for Pyridazine Amides <b>9</b>, <b>18</b>â<b>20</b>, <b>22</b>, and <b>23</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">LYSA<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (Î¼g/mL)</th><th class="colsep0 rowsep0" align="center">CACO2 AB<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (ER)</th><th class="colsep0 rowsep0" align="center">PPB<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (% free)</th><th class="colsep0 rowsep0" align="center">CYP450 IC<sub>50</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a> (Î¼M)</th><th class="colsep0 rowsep0" align="center">HLM<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a> (mL/(minÂ·kg))</th><th class="colsep0 rowsep0" align="center">RLM<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a> (mL/(minÂ·kg))</th><th class="colsep0 rowsep0" align="center">MLM<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a> (mL/(minÂ·kg))</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">471</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">390</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">329</td><td class="colsep0 rowsep0" align="left">1.8Â (7)</td><td class="colsep0 rowsep0" align="left">15.4</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">345</td><td class="colsep0 rowsep0" align="left">3.9Â (4)</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">16 (2D6)</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">404</td><td class="colsep0 rowsep0" align="left">2.7Â (6)</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">522</td><td class="colsep0 rowsep0" align="left">0.5Â (23)</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">33 (2D6)</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">â</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Lyophilized solubility assay.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Apical to basolateral CACO2 permeability, followed by measured efflux ratio.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Human plasma protein binding % free fraction.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">CYP450 inhibition at isoforms 3A4, 2C9, and 2D6. Lowest inhibition value indicated.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Stability in human liver microsomes.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">Stability in rat liver microsomes.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Stability in mouse liver microsomes.</p></div></div></div><div class="NLM_p">We quickly expanded our SAR exploration and soon obtained an X-ray crystal structure of <b>14</b> bound to the Syk protein that confirmed the expected binding mode. The 6-ethyl group of the pyridine projects out over the Pro455, and the <i>cis</i>-cyclohexyldiamino moiety forms a hydrogen bond via its secondary amine and a salt bridge via its primary amine to the carboxy side chain of Asn512 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). For our initial SAR exploration, we kept the <i>cis</i>-cyclohexyldiamino portion constant so that we could focus on optimizing selectivity and potency by modifying the 2-aminopyridine portion of the scaffold.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of <b>14</b> bound to Syk.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Highlights of our initial SAR study of substitution on the 2-aminopyridine moiety are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. As we increased the size of the 6-alkyl substituent, we observed an increase in potency. However, this did not translate into improved human whole blood (HWB) activity. Since the HWB assay is not a target-based assay but a functional assay, we could not completely rule out other off-target activities imparting a component of the observed activities. However, we do believe that the potency is driven primarily through the Syk activity: In our 30 kinase panel, we included several kinases involved in the B-cell signaling pathway that were not strongly inhibited (e.g., Akt, Lyn, Btk, Erk). The increase in clogP accompanied by the increased size also led to an increase in hERG channel inhibition, and a slight loss of kinome selectivity, which is in line with general reports that lipophilicity is often a driver of off-target activity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We next investigated maintaining the 6-methyl substituent and the effect of additional substitution on the pyridine ring. At the 5-position, fluorine (<b>18</b>), methyl (<b>19</b>), and chlorine (<b>20</b>) all maintained similar potency in the enzyme and HWB assays, with <b>18</b> and <b>20</b> also improving cell-based selectivity. Substitution at the 4-position was generally detrimental to selectivity (<b>21)</b>. This is noteworthy as it suggests an advantage of our series. We believe that the pyridine nitrogen strongly favors the conformation that projects the R<sup>1</sup> substituent over the Pro455, improving selectivity over the kinome. If other conformations were sampled, as is likely the case for <b>2</b> and <b>3</b>, then the potential to bind to additional kinases is increased. The lower selectivity of pseudosymmetric 4,6-dimethylpyridine compound <b>21</b> supports this.</div><div class="NLM_p">Comfortable that we were able to achieve sufficient hERG safety windows, cell selectivity, and good human whole blood potency, we profiled several molecules from the series in biopharmaceutical and early safety assays. No significant CYP450 inhibition or time-dependent inhibition was detected. No GSH adducts were detected, and the compounds generally had high to moderate stability in human and rat liver microsomes. Microsomal clearance correlated well with hepatocyte clearance (unpublished results). With no mutagenicity or carcinogenicity in silico alerts, the prospects for the series seemed excellent. We obtained mouse PK on several compounds with a good balance of cell selectivity and safety profiles (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) in order to assess the suitability of the scaffold for assessment in the mouse collagen induced arthritis efficacy model of rheumatoid arthritis and further assess the potential of the scaffold. 5-F-6-Me pyridine (<b>18</b>) and 5-Cl-6-Me pyridine (<b>20</b>) both show a good PK profile. 5,6-dimethyl (<b>19</b>) showed more moderate PK but showed good enzyme and cell-based selectivity, was exceptionally potent in human whole blood, and also displayed the largest hERG window of the compounds that we had synthesized at that point. Thus, <b>19</b> was selected to investigate as a representative to probe the in vivo mCIA efficacy study (See the Experimental Section, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>, for details). When tested in a standard mouse model of collagen-induced arthritis, <b>19</b> displayed excellent levels of efficacy, inhibiting arthritis scores in a dose-dependent manner at the dose range 5â45 mg/kg by as much as 64% (45 mg/kg, once a day), an efficacy that is comparable to that of R788 (58%, 30 mg/kg, twice a day). That the compound displayed comparable efficacy to R788, a nonselective Syk inhibitor that has shown to be efficacious in patients with rheumatoid arthritis, suggested to us that a selective Syk inhibitor such as <b>19</b> may bring the same efficacy benefit to patients as R788, while reducing potential for off-target toxicity (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters after a Single Dosing in Mouse for Compounds <b>18</b>â<b>20</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL<sub>iv</sub> (mL/(minÂ·kg))</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub><sup>1</sup>/<sub>2</sub></sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">PO dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">AUC/dose ((ng/(mLÂ·h))/(mg/kg))</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">5.57</td><td class="colsep0 rowsep0" align="left">1.44</td><td class="colsep0 rowsep0" align="left">3.26</td><td class="colsep0 rowsep0" align="left">1560</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">568</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">25.9</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>20</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">mouse</td><td class="colsep0 rowsep0" rowspan="2" align="left">8.65</td><td class="colsep0 rowsep0" rowspan="2" align="left">2.74</td><td class="colsep0 rowsep0" rowspan="2" align="left">3.92</td><td class="colsep0 rowsep0" align="left">386</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">970</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1440</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">753</td><td class="colsep0 rowsep0" align="left">40</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last"><i>n</i> = 2â3 per time point. IV dose = 0.5 mg/kg; PO dose = 5 or 30 mg/kg. NA = not available. ND = not determined. Blood samples were collected from each animal at selected times postdose for the determination of compound levels in plasma. The samples were collected into tubes containing potassium EDTA, as an anticoagulant and stabilizer, and were processed to plasma and kept in a freezer set to maintain â80 Â°C. The pharmacokinetic parameters were estimated using the individual plasma concentration data for rat or pooled mean plasma concentration data for mouse. Nominal sampling times were reported and were used for kinetic calculations. Concentrations below the limit of quantitation (BLQ) were not used. The extrapolated area under the plasma concentrationâtime curve from zero to infinity (AUC), apparent terminal half-life (<i>t</i><sub><sup>1</sup>/<sub>2</sub></sub>), the total plasma clearance (CL), the volume of distribution at steady state (<i>V</i><sub>dss</sub>), <i>F</i>%, bioavailability after a single oral dosing relative to a single IV dosing corrected by doses, and dose normalized AUC (AUC/dose).</p></div></div></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Flat molecules are known to be DNA intercalators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Clinical scores from the assessment of <b>19</b> in the mouse collagen-induced arthritis model. Collagen-induced arthritis was induced in young adult male DBA1/J mice (7â8 weeks of age) as described previously by immunizing them twice with bovine type II collagen.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Test compound was administered orally once a day for 14 days starting the day after the second immunization. Arthritis was monitored by observing redness and swelling of the paws or digits and given a clinical score based on a scale of 0â4 per paw with 4 being the most severe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While this work was in progress, we encountered a report from GlaxoSmithKline in which they presented data for <b>3</b>, a member of the diaminopyrimidine scaffold and closely related to Portola clinical candidate <b>2</b>. We were surprised to learn that <b>3</b> showed mutagenicity in salmonella test strain TA1537. While our series had not shown any mutagenicity flag in silico, we noted that the in silico prediction for the pyrimidine <b>3</b> scaffold did not have an alert either. We promptly tested representatives of our pyridazine series (<b>9</b> and <b>14</b>) in the Ames assay, and while no signal was observed in our standard panel of five salmonella strains (unpublished results), when we tested the compounds in TA1537, a clear signal was observed, both in the presence and absence of liver S9 fraction.</div><div class="NLM_p">Every compound that we subsequently tested showed mutagenicity in the TA1537 strain, including those in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. To account for this, we immediately began further syntheses to develop SAR and find nonmutagenic examples (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Replacing the <i>cis</i>-diaminocyclohexyl moiety with ethylene diamine (<b>24</b>) retained potency but did not eliminate the mutagenicity flag. In contrast, the 2-aminoethyl ether (<b>25</b>), simple cyclohexylamine (<b>28</b>), and ether linked phenyl (<b>27</b>) were all clearly negative in Ames. Replacement of the 2-amino-4,6-dimethyl-pyridine with 3,5-dimethylaniline provided nonmutagenic (<b>26</b>). Unfortunately, these nonmutagenic compounds showed diminished binding to the Syk protein (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). We also found it hard to rationalize the significant impact that these apparently subtle changes had on the mutagenicity result, making it challenging to create a design strategy.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of Syk Activity<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>, Human Whole Blood Potency<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>, and Ames Mutagenicity<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> Results for Pyridazine Amides <b>24</b>â<b>28</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">See the Experimental Section (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) for details; data shown is the average of at least <i>n</i> = 2.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Human whole blood pIC<sub>50</sub>.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Ames mutagenicity assay category, in the presence (+S9) and absence (âS9) of liver S9 fraction.</p></div></div><div></div></div><div class="NLM_p">The Ames assay is essentially binary, and even âweakâ mutagens are prohibited from entering clinical trials. However, close inspection of the data (unpublished results) showed that the number of reverting bacterial colonies trended downward as the steric size of the 6-substituents on the pyridine ring increased. Since mutagenicity was observed both in the presence and in the absence of metabolic activation, we hypothesized that it was the shape of the molecule that was driving mutagenicity. We had designed the pyridazine scaffold with internal hydrogen bonds to control the conformation and allow us to optimize hydrophobic interactions with Pro455. A consequence of this was also to lock the majority of the molecules into flat, pseudo-polyaromatic fused ring systems, somewhat resembling the anthraquinones, which are known DNA intercalators and mutagens (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">We speculated that the flat topology might promote dsDNA intercalation and that subsequent frame shift mutations were the cause of the observed Ames mutagenicity. Therefore, we sought to incrementally increase the ovality (a computed measure of thickness) of the molecules until the fit into the DNA major groove was poor enough to switch off the mutagenicity. We hoped that we would be able to retain the potency and other good biopharmaceutical properties that had made the scaffold so desirable at the outset.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Compounds that exhibited greater âovalityâ and were nonmutagenic in the Ames assay were quickly identified: <i>tert</i>-butyl derivative <b>29</b> and 5-methyl-6-isopropyl compound <b>31</b>. These provided early support for the DNA intercalation hypothesis and suggested that the scaffold still offered great potential to deliver clinical candidates. Next, compounds were designed to better define the appropriate target ovality. Retrospectively, we found that the ovality of the largest fragment (subtracting the diamine right-hand piece) best predicted the Ames mutagenicity result. We were able to use this predictive model to prioritize our synthetic targets (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). To trigger synthesis of our designed targets, we required that the predicted ovality score was greater than 1.44.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Average ovality and relationship to mutagenicity. Ovality was measured based on the fragment shown. 74% of compounds mutagenic if ovality <1.44, while 67% of compounds nonmutagenic or inconclusive had ovality >1.44.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We became confident in our ability to design compounds that were nonmutagenic by increasing the ovality of the molecules, and while not perfect, we were able to identify multiple structures that were no longer mutagenic (â¼67% success rate). However, the increased ovality of the first nonmutagenic compounds led to encroachment on suboptimal chemical property space,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> where the risk of off-target effects and attrition rates increase. Not only was the measured HWB potency negatively impacted, but the increased lipophilicity also reduced enzyme panel and cell selectivity and often reduced the therapeutic window between hERG binding and HWB potency (e.g., <b>29</b>â<b>33</b>, Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibition of Syk Activity<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>, Selectivity<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a>, Human Whole Blood Potency<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a>, and hERG Channel Inhibition<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a> by Pyridazine Amides <b>29</b>â<b>39</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0013.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0014.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">See the Experimental Section (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) for details; data shown is the average of at least <i>n</i> = 2.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Carna Bioscience Inc. screening platform measurements employing an enzyme binding assay to quantitatively measure interactions between test compounds at 1 Î¼M and a panel of 30 kinases.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Ratio of Jurkat T cell IC<sub>50</sub> divided by Ramos B cell IC<sub>50</sub>.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Human whole blood pIC<sub>50</sub>.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">hERG channel pIC<sub>50</sub>.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Solubility<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a>, Permeability<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>, Human Plasma Protein Binding<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a>, CYP450 Inhibition<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a>, and Liver Microsomal Stability<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a>,<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a>,<a class="ref internalNav" href="#t6fn7" aria-label="g">g</a> for Pyridazine Amides</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">LYSA<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> (Î¼g/mL)</th><th class="colsep0 rowsep0" align="center">CACO2 AB<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (ER)</th><th class="colsep0 rowsep0" align="center">PPB<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (% free)</th><th class="colsep0 rowsep0" align="center">CYP450 IC<sub>50</sub><a class="ref internalNav" href="#t6fn4" aria-label="d">d</a> (Î¼M)</th><th class="colsep0 rowsep0" align="center">HLM<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a> (mL/(minÂ·kg))</th><th class="colsep0 rowsep0" align="center">RLM<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a> (mL/(minÂ·kg))</th><th class="colsep0 rowsep0" align="center">MLM<a class="ref internalNav" href="#t6fn7" aria-label="g">g</a>(mL/(minÂ·kg))</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">9.3Â (2)</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">25(2D6)</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">5.1Â (0.4)</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">39 (2D6)</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">134</td><td class="colsep0 rowsep0" align="left">3.1Â (2)</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">18 (2D6)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">106</td><td class="colsep0 rowsep0" align="left">4.0Â (3)</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">8 (3A4)</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">â</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">1284</td><td class="colsep0 rowsep0" align="left">7.5Â (2)</td><td class="colsep0 rowsep0" align="left">11.1</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">3.8Â (3)</td><td class="colsep0 rowsep0" align="left">14.4</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1.3Â (12)</td><td class="colsep0 rowsep0" align="left">18.8</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">168</td><td class="colsep0 rowsep0" align="left">0.8Â (9)</td><td class="colsep0 rowsep0" align="left">16.1</td><td class="colsep0 rowsep0" align="left">45 (2D6)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">159</td><td class="colsep0 rowsep0" align="left">7.4Â (2)</td><td class="colsep0 rowsep0" align="left">â</td><td class="colsep0 rowsep0" align="left">38 (2D6)</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.0Â (9)</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left">34 (2D6)</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">â</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Lyophilized solubility assay.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Apical to basolateral CACO2 permeability, followed by measured efflux ratio.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Human plasma protein binding % free fraction.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">CYP450 inhibition at isoforms 3A4, 2C9, and 2D6. Lowest inhibition value indicated.</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">Stability in human liver microsomes.</p></div><div class="footnote" id="t6fn6"><sup>f</sup><p class="last">Stability in rat liver microsomes.</p></div><div class="footnote" id="t6fn7"><sup>g</sup><p class="last">Stability in mouse liver microsomes.</p></div></div></div><div class="NLM_p">Mining of the hERG data for the series suggested that we needed to target a clogP of less than three in order to improve our chances of achieving a sufficient therapeutic window over hERG. Thus, we defined a hypothetical âsafe zoneâ and used this as a gate when designing new compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Compounds were prioritized if they were predicted to be nonmutagenic based on their thickness (ovality) and expected to be poor hERG channel inhibitors with improved human whole blood potency based on their lipophilicity (clogP). Any molecule that fell outside of this zone was deprioritized or refined further to shift it closer to the desired parameters.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Plot of ovality, clogP, and Ames mutagenicity result (No = not mutagenic in any of the five strains tested; Yes = mutagenic in at least one of the five strains tested; Inconclusive = number of reverting colonies just exceeded threshold of 2-fold increase over control). Properties describing a hypothetical âsafe zoneâ is depicted as a green oval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among the modifications that were able to reduce the clogP, the 1,2-diaminoethyl and the 3,4-diaminotetrahydropyran groups generally maintained good potency and imparted a beneficial effect on hERG windows relative to the 1,2-diaminocyclohexyl moiety. This is likely due to the reduction in clogP in both cases as well as a reduction in the p<i>K</i><sub>a</sub> in the case of the 3,4-diaminotetrahydropyran group. Earlier SAR based on matched pairs had identified that substitution in the 5-position of the 2-aminopyridyl group, particularly with a small hydrophobe such as fluorine or an alkyl (e.g., <b>18</b> vs <b>9</b> and <b>19</b> vs <b>9</b>), also tended to reduce hERG binding. SAR also showed methoxy substituents on the 2-aminopyridine tended to reduce the clogP as well as improve potency. Thus, we concentrated on generating targets that married these components together in an effort to find nonmutagenic compounds with a good balance of in vitro properties.</div><div class="NLM_p">In this regard, we identified a number of compounds that offered an excellent balance of in vitro criteria (Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, <b>34</b>â<b>39</b>). This selection of top compounds was refined further by PK profiling, and from this refinement, <b>34</b>, <b>36</b>, and <b>37</b> emerged as excellent candidates (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). All three showed very promising PK profiles in mice, with high oral bioavailability and AUC values. All three met our strict in vitro and in vivo requirements, and as such, the compounds were difficult to segregate further. Compound <b>34</b> was less selective in our cell-based assay but had the advantage that it showed the best solubility and permeability. Compounds <b>36</b> and <b>37</b> were essentially indistinguishable. To further derisk the series, <b>37</b> was subjected to further safety screening. We were pleased to find that this compound (in line with expectations based on results of other scaffold representatives, data not shown) was not carcinogenic in the MNT assay (unpublished results) and as such confirmed for us that all three remained excellent candidates and deserved further investigation in vivo for potential progression toward the clinic.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Parameters after a Single Dosing in Mouse for Compounds <b>34</b>, <b>36</b>, and <b>37</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL<sub>iv</sub> (mL/(minÂ·kg))</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub><sup>1</sup>/<sub>2</sub></sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center">AUC/dose ((ng/(mLÂ·h))/(mg/kg))</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>34</b></td><td class="colsep0 rowsep0" align="center">Mouse</td><td class="colsep0 rowsep0" align="center">42.2</td><td class="colsep0 rowsep0" align="center">1.96</td><td class="colsep0 rowsep0" align="center">3.67</td><td class="colsep0 rowsep0" align="center">365</td><td class="colsep0 rowsep0" align="center">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>36</b></td><td class="colsep0 rowsep0" align="center">Mouse</td><td class="colsep0 rowsep0" align="center">16.7</td><td class="colsep0 rowsep0" align="center">1.74</td><td class="colsep0 rowsep0" align="center">1.40</td><td class="colsep0 rowsep0" align="center">609</td><td class="colsep0 rowsep0" align="center">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>37</b></td><td class="colsep0 rowsep0" align="center">Mouse</td><td class="colsep0 rowsep0" align="center">8.52</td><td class="colsep0 rowsep0" align="center">1.28</td><td class="colsep0 rowsep0" align="center">0.63</td><td class="colsep0 rowsep0" align="center">1470</td><td class="colsep0 rowsep0" align="center">75</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last"><i>n</i> = 2â3 per time point. IV dose = 1 mg/kg; PO dose = 10 or 20 mg/kg.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have identified a highly efficacious and Syk selective scaffold to enable further investigation of the merits of Syk inhibition as a target to treat various diseases. To the best of our knowledge, these molecules are superior to all Syk inhibitors that have been published to date. On the basis of hypothesis and careful prioritization, we identified several compounds that are nonmutagenic and maintain excellent druglike properties and whole blood potencies. Compounds <b>34</b>, <b>36</b>, and <b>37</b> are noteworthy for their combination of human whole blood potency, kinome selectivity, good therapeutic window over hERG, and low risk of mutagenicity or carcinogenicity. They represent excellent pharmacological tools for the further investigation of selective Syk inhibitors in disease mitigation. The fate of these molecules will be the subject of future communications.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12"><a href="/doi/suppl/10.1021/jm401982j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30877" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30877" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for synthesis of final compounds and intermediates, and descriptions of assays performed. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401982j/suppl_file/jm401982j_si_001.pdf">jm401982j_si_001.pdf (729.12 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401982j" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew C. Lucas</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#95f8f4e1e1fdf0e2bbf9e0f6f4e6d5f6e0f7fce6e1bbf6faf8"><span class="__cf_email__" data-cfemail="f29f9386869a9785dc9e87919381b29187909b8186dc919d9f">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niala Bhagirath</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Chiao</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Goldstein</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johannes C. Hermann</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pei-Yuan Hsu</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephan Kirchner</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, Grenzacherstrasse 124, 4070 Basle, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua J. Kennedy-Smith</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Kuglstatter</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Lukacs</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Menke</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linghao Niu</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Padilla</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Peng</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liudmila Polonchuk</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, Grenzacherstrasse 124, 4070 Basle, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aruna Railkar</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Slade</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Soth</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daigen Xu</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Preeti Yadava</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Calvin Yee</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingyan Zhou</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Liao</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche
Inc., pRED, Pharma Research & Early Development, Small Molecule
Research, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d45e2167-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Karen Lackey, Satwant Narula, and Julie DeMartino for their leadership and critical strategic discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i15" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i15"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i16" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i16"> Abbreviations Used</h2><tr><td class="NLM_term">Syk</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systemic lupus erythematous</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">PLCÎ³</td><td class="NLM_def"><p class="first last">phospholipase CÎ³</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">SLP</td><td class="NLM_def"><p class="first last">SH2 domain containing leukocyte protein</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small inhibitory ribonucleic acid</p></td></tr><tr><td class="NLM_term">BCR</td><td class="NLM_def"><p class="first last">B-cell receptor</p></td></tr><tr><td class="NLM_term">VEGFR2</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor 2</p></td></tr><tr><td class="NLM_term">RET</td><td class="NLM_def"><p class="first last">rearranged during transfection tyrosine kinase</p></td></tr><tr><td class="NLM_term">MLK1</td><td class="NLM_def"><p class="first last">mixed-lineage kinase 1</p></td></tr><tr><td class="NLM_term">Met</td><td class="NLM_def"><p class="first last">methionine</p></td></tr><tr><td class="NLM_term">Leu</td><td class="NLM_def"><p class="first last">leucine</p></td></tr><tr><td class="NLM_term">Btk</td><td class="NLM_def"><p class="first last">Brutonâs tyrosine kinase</p></td></tr><tr><td class="NLM_term">Jak</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimthylsulfoxide</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">X-Phos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2â²,4â²,6â²-triisopropylbiphenyl</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium(0)</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">(2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">PTSA</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Mocsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase: A crucial player in diverse biological functions</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1038%2Fnri2765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=20467426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=387-402&author=A.+Mocsaiauthor=J.+Rulandauthor=V.+L.+J.+Tybulewicz&title=The+SYK+tyrosine+kinase%3A+A+crucial+player+in+diverse+biological+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The SYK tyrosine kinase: a crucial player in diverse biological functions</span></div><div class="casAuthors">Mocsai, Attila; Ruland, Jurgen; Tybulewicz, Victor L. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">387-402</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (SYK) is known to have a crucial role in adaptive immune receptor signalling.  However, recent reports indicate that SYK also mediates other, unexpectedly diverse biol. functions, including cellular adhesion, innate immune recognition, osteoclast maturation, platelet activation and vascular development.  SYK is activated by C-type lectins and integrins, and activates new targets, including the CARD9-BCL-10-MALT1 pathway and the NLRP3 inflammasome.  Studies using Drosophila melanogaster suggest that there is an evolutionarily ancient origin of SYK-mediated signalling.  Moreover, SYK has a crucial role in autoimmune diseases and haematol. malignancies.  This Review summarizes our current understanding of the diverse functions of SYK and how this is being translated for therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3YO5BcMqrf7Vg90H21EOLACvtfcHk0lgqerOQFEj6pg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D&md5=85857a2b9beb84e0fe74263a90fa8a53</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri2765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2765%26sid%3Dliteratum%253Aachs%26aulast%3DMocsai%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%253A%2520A%2520crucial%2520player%2520in%2520diverse%2520biological%2520functions%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D387%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bajpai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase: A novel target for therapeutic intervention of rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">â</span> <span class="NLM_lpage">659</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=641-659&author=M.+Bajpaiauthor=P.+Chopraauthor=S.+G.+Dastidarauthor=A.+Ray&title=Spleen+tyrosine+kinase%3A+A+novel+target+for+therapeutic+intervention+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBajpai%26aufirst%3DM.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DDastidar%26aufirst%3DS.%2BG.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DSpleen%2520tyrosine%2520kinase%253A%2520A%2520novel%2520target%2520for%2520therapeutic%2520intervention%2520of%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D641%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Zou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shattil, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span> </span><span class="NLM_article-title">Syk, c-Src, the Î±vÎ²3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">â</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2007&pages=877-888&author=W.+Zouauthor=H.+Kitauraauthor=J.+Reeveauthor=F.+Longauthor=V.+L.+Tybulewiczauthor=S.+J.+Shattilauthor=M.+H.+Ginsbergauthor=F.+P.+Rossauthor=S.+L.+Teitelbaum&title=Syk%2C+c-Src%2C+the+%CE%B1v%CE%B23+integrin%2C+and+ITAM+immunoreceptors%2C+in+concert%2C+regulate+osteoclastic+bone+resorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DW.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DReeve%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26aulast%3DShattil%26aufirst%3DS.%2BJ.%26aulast%3DGinsberg%26aufirst%3DM.%2BH.%26aulast%3DRoss%26aufirst%3DF.%2BP.%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26atitle%3DSyk%252C%2520c-Src%252C%2520the%2520%25CE%25B1v%25CE%25B23%2520integrin%252C%2520and%2520ITAM%2520immunoreceptors%252C%2520in%2520concert%252C%2520regulate%2520osteoclastic%2520bone%2520resorption%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D176%26spage%3D877%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Koga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suematsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, T.</span><span> </span><span class="NLM_article-title">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">â</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1038%2Fnature02444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=15085135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=758-763&author=T.+Kogaauthor=M.+Inuiauthor=K.+Inoueauthor=S.+Kimauthor=A.+Suematsuauthor=E.+Kobayashiauthor=T.+Iwataauthor=H.+Ohnishiauthor=T.+Matozakiauthor=T.+Kodamaauthor=T.+Taniguchiauthor=H.+Takayanagiauthor=T.+Takai&title=Costimulatory+signals+mediated+by+the+ITAM+motif+cooperate+with+RANKL+for+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span></div><div class="casAuthors">Koga, Takako; Inui, Masanori; Inoue, Kazuya; Kim, Sunhwa; Suematsu, Ayako; Kobayashi, Eiji; Iwata, Toshio; Ohnishi, Hiroshi; Matozaki, Takashi; Kodama, Tatsuhiko; Taniguchi, Tadatsugu; Takayanagi, Hiroshi; Takai, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6984</span>),
    <span class="NLM_cas:pages">758-763</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Costimulatory signals are required for activation of immune cells, but it is not known whether they contribute to other biol. systems.  The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption.  Receptor activator of NF-ÎºB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF).  But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis.  Here the authors show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)-harboring adaptors, Fc receptor common Î³ subunit (FcRÎ³) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation.  In osteoclast precursor cells, FcRÎ³ and DAP12 assoc. with multiple immunoreceptors and activate calcium signaling through phospholipase CÎ³.  Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis.  These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvHiH4e8xvSLVg90H21EOLACvtfcHk0ljPjg3l30VsBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D&md5=cc70a7455fe1d9932271758c2791eac5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature02444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02444%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSuematsu%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DE.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DH.%26aulast%3DMatozaki%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DH.%26aulast%3DTakai%26aufirst%3DT.%26atitle%3DCostimulatory%2520signals%2520mediated%2520by%2520the%2520ITAM%2520motif%2520cooperate%2520with%2520RANKL%2520for%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D758%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tam, F. W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAdoo, S. P.</span><span> </span><span class="NLM_article-title">Fostamatinib disodium</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1358%2Fdof.2011.036.04.1588554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=23284223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1ylurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=273-280&author=F.+W.+K.+Tamauthor=S.+P.+McAdoo&title=Fostamatinib+disodium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Fostamatinib disodium: tyrosine-protein kinase SYK/FLT3 inhibitor treatment of rheumatoid arthritis oncolytic</span></div><div class="casAuthors">McAdoo, S. P.; Tam, F. W. K.; Pandian, R.; Bolos, J.; Castaner, R.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-280</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The non-receptor tyrosine-protein kinase SYK (spleen tyrosine kinase) has a diverse range of biol. functions, including a crit. role in the intracellular signaling cascade for the surface Ig receptor on B lymphocytes and the Fc receptor expressed on numerous immune effector cells.  It is therefore seen as a potential therapeutic target in a variety of conditions, including autoimmune, allergic and malignant diseases.  Fostamatinib disodium is the orally bioavailable prodrug of R-406, a relatively selective small-mol. inhibitor of SYK, that has accordingly shown activity in numerous cell types in vitro, and efficacy in a remarkable range of animal models in vivo, including rodent models of asthma, inflammatory arthritis, lupus, glomerulonephritis, diabetes and lymphoma.  Success in these models has translated to phase II clin. trials in autoimmune thrombocytopenia, lymphoma and, most notably, rheumatoid arthritis, in which larger phase III trials are currently in progress.  While the diverse biol. functions of SYK coupled with the potential off-target effects of this kinase inhibitor are a source of possible toxicity, the available data thus far augur well for future clin. use of fostamatinib in a wide range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1UBbKHhezKrVg90H21EOLACvtfcHk0ljPjg3l30VsBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1ylurs%253D&md5=762da3b1321b7eadbe9ae531221b5593</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.04.1588554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.04.1588554%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DF.%2BW.%2BK.%26aulast%3DMcAdoo%26aufirst%3DS.%2BP.%26atitle%3DFostamatinib%2520disodium%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D273%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pandey, A.</span><span> </span><span class="NLM_article-title">Discovery of PRT062607: A potent and selective Syk inhibitor for the treatment of inflammatory, B cell proliferative diseases and thrombosis</span>. CHI 6th Annual Drug Discovery Chemistry Conference, San Diego, CA, April 12â13,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Pandey&title=Discovery+of+PRT062607%3A+A+potent+and+selective+Syk+inhibitor+for+the+treatment+of+inflammatory%2C+B+cell+proliferative+diseases+and+thrombosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520PRT062607%253A%2520A%2520potent%2520and%2520selective%2520Syk%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%252C%2520B%2520cell%2520proliferative%2520diseases%2520and%2520thrombosis%26jtitle%3DCHI%25206th%2520Annual%2520Drug%2520Discovery%2520Chemistry%2520Conference%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coffey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGuzman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbach, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, U.</span><span> </span><span class="NLM_article-title">Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">â</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1124%2Fjpet.111.188441" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=350-359&author=G.+Coffeyauthor=F.+DeGuzmanauthor=M.+Inagakiauthor=Y.+Pakauthor=S.+M.+Delaneyauthor=D.+Ivesauthor=A.+Betzauthor=Z.+J.+Jiaauthor=A.+Pandeyauthor=D.+Bakerauthor=S.+J.+Hollenbachauthor=D.+R.+Phillipsauthor=U.+Sinha&title=Specific+inhibition+of+spleen+tyrosine+kinase+suppresses+leukocyte+immune+function+and+inflammation+in+animal+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.188441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.188441%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DG.%26aulast%3DDeGuzman%26aufirst%3DF.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DPak%26aufirst%3DY.%26aulast%3DDelaney%26aufirst%3DS.%2BM.%26aulast%3DIves%26aufirst%3DD.%26aulast%3DBetz%26aufirst%3DA.%26aulast%3DJia%26aufirst%3DZ.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DSinha%26aufirst%3DU.%26atitle%3DSpecific%2520inhibition%2520of%2520spleen%2520tyrosine%2520kinase%2520suppresses%2520leukocyte%2520immune%2520function%2520and%2520inflammation%2520in%2520animal%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D34%26spage%3D350%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gilead</span><span class="NLM_x">. Pipeline. </span><a href="http://www.gilead.com/pipeline" class="extLink">http://www.gilead.com/pipeline</a> (accessed February 2014).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gilead.+Pipeline.+http%3A%2F%2Fwww.gilead.com%2Fpipeline+%28accessed+February+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elwes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garton, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhow, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, A. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez-Molina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weingarten, G. G.</span><span> </span><span class="NLM_article-title">Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6188</span><span class="NLM_x">â</span> <span class="NLM_lpage">6194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6188-6194&author=J.+Liddleauthor=F.+L.+Atkinsonauthor=M.+D.+Barkerauthor=P.+S.+Carterauthor=N.+R.+Curtisauthor=R.+P.+Davisauthor=C.+Douaultauthor=M.+C.+Dicksonauthor=D.+Elwesauthor=N.+S.+Gartonauthor=M.+Grayauthor=T.+G.+Hayhowauthor=C.+I.+Hobbsauthor=E.+Jonesauthor=S.+Leachauthor=K.+Leavensauthor=H.+D.+Lewisauthor=S.+McClearyauthor=M.+Neuauthor=V.+K.+Patelauthor=A.+G.+S.+Prestonauthor=C.+Ramirez-Molinaauthor=T.+J.+Shipleyauthor=P.+A.+Skoneauthor=N.+Smithersauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=R.+J.+Watsonauthor=G.+G.+Weingarten&title=Discovery+of+GSK143%2C+a+highly+potent%2C+selective+and+orally+efficacious+spleen+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DAtkinson%26aufirst%3DF.%2BL.%26aulast%3DBarker%26aufirst%3DM.%2BD.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DCurtis%26aufirst%3DN.%2BR.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DDouault%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DM.%2BC.%26aulast%3DElwes%26aufirst%3DD.%26aulast%3DGarton%26aufirst%3DN.%2BS.%26aulast%3DGray%26aufirst%3DM.%26aulast%3DHayhow%26aufirst%3DT.%2BG.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DS.%26aulast%3DLeavens%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DPreston%26aufirst%3DA.%2BG.%2BS.%26aulast%3DRamirez-Molina%26aufirst%3DC.%26aulast%3DShipley%26aufirst%3DT.%2BJ.%26aulast%3DSkone%26aufirst%3DP.%2BA.%26aulast%3DSmithers%26aufirst%3DN.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26aulast%3DWeingarten%26aufirst%3DG.%2BG.%26atitle%3DDiscovery%2520of%2520GSK143%252C%2520a%2520highly%2520potent%252C%2520selective%2520and%2520orally%2520efficacious%2520spleen%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6188%26epage%3D6194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Clemens, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magness, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lech, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span> <span class="citation_source-journal">Birth Defects Res., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">â</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1002%2Fbdra.20505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=19107952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=130-136&author=G.+R.+Clemensauthor=R.+E.+Schroederauthor=S.+H.+Magnessauthor=E.+V.+Weaverauthor=J.+W.+Lechauthor=V.+C.+Taylorauthor=E.+S.+Masudaauthor=M.+Baluomauthor=E.+B.+Grossbard&title=Developmental+toxicity+associated+with+receptor+tyrosine+kinase+Ret+inhibition+in+reproductive+toxicity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span></div><div class="casAuthors">Clemens, George R.; Schroeder, Raymond E.; Magness, Steven H.; Weaver, Elizabeth V.; Lech, Joseph W.; Taylor, Vanessa C.; Masuda, Esteban S.; Baluom, Muhammad; Grossbard, Elliott B.</div><div class="citationInfo"><span class="NLM_cas:title">Birth Defects Research, Part A: Clinical and Molecular Teratology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-136</span>CODEN:
                <span class="NLM_cas:coden">BDRPBT</span>;
        ISSN:<span class="NLM_cas:issn">1542-0752</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Urogenital abnormalities are among the most common of all human birth defects.  In developmental toxicity studies with the Syk kinase inhibitor R788, a spectrum of findings, including renal agenesis, were obsd.  R788 was also found to inhibit the receptor tyrosine kinase Ret.  Ret kinase is known to be an essential component in the signaling pathway required for renal organogenesis and ureteric duct formation.  Previously known is that mutant mice without the c-ret gene, develop urogenital malformations including renal agenesis.  In GLP developmental toxicity studies, gravid rabbits were treated orally with R788 at doses of 0, 10, 22, and 50 mg/kg/day (gestation days 7-19) and gravid rats received 0, 5, 12.5, and 25 mg/kg/day (gestation days 6-17) by the same route.  The activity of R406 against Ret kinase was assessed in biochem. and cell-based assays.  A dose-dependent increase in malformations, including renal and ureteric agenesis and a specific major vessel anomaly, retro-esophageal right subclavian artery, was obsd. in both the rat and rabbit.  R788 proved to be a potent inhibitor of Ret kinase.  R788 promoted a spectrum of developmental toxicity, including renal and ureteric agenesis and a specific major vessel abnormality, retro-esophageal right subclavian artery, in 2 different species.  These effects are likely the result of inhibition of Ret kinase given its importance in the normal ontogeny of the urogenital and cardiovascular systems across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkk1lYWlmwebVg90H21EOLACvtfcHk0lgW301N6-mtJA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D&md5=9cd3909537d2d22ce666d1e0e426ec7c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fbdra.20505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdra.20505%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DG.%2BR.%26aulast%3DSchroeder%26aufirst%3DR.%2BE.%26aulast%3DMagness%26aufirst%3DS.%2BH.%26aulast%3DWeaver%26aufirst%3DE.%2BV.%26aulast%3DLech%26aufirst%3DJ.%2BW.%26aulast%3DTaylor%26aufirst%3DV.%2BC.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DDevelopmental%2520toxicity%2520associated%2520with%2520receptor%2520tyrosine%2520kinase%2520Ret%2520inhibition%2520in%2520reproductive%2520toxicity%2520testing%26jtitle%3DBirth%2520Defects%2520Res.%252C%2520Part%2520A%26date%3D2009%26volume%3D85%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Friedberg, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetenham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vose, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacasce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer-Cutillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cripe, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterba, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipp, M. A.</span><span> </span><span class="NLM_article-title">Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2578</span><span class="NLM_x">â</span> <span class="NLM_lpage">2585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2578-2585&author=J.+W.+Friedbergauthor=J.+Sharmanauthor=J.+Sweetenhamauthor=P.+B.+Johnstonauthor=J.+M.+Voseauthor=A.+Lacasceauthor=J.+Schaefer-Cutilloauthor=S.+De+Vosauthor=R.+Sinhaauthor=J.+P.+Leonardauthor=L.+D.+Cripeauthor=S.+A.+Gregoryauthor=M.+P.+Sterbaauthor=A.+M.+Loweauthor=R.+Levyauthor=M.+A.+Shipp&title=Inhibition+of+Syk+with+fostamatinib+disodium+has+significant+clinical+activity+in+non-Hodgkin+lymphoma+and+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedberg%26aufirst%3DJ.%2BW.%26aulast%3DSharman%26aufirst%3DJ.%26aulast%3DSweetenham%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DP.%2BB.%26aulast%3DVose%26aufirst%3DJ.%2BM.%26aulast%3DLacasce%26aufirst%3DA.%26aulast%3DSchaefer-Cutillo%26aufirst%3DJ.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DJ.%2BP.%26aulast%3DCripe%26aufirst%3DL.%2BD.%26aulast%3DGregory%26aufirst%3DS.%2BA.%26aulast%3DSterba%26aufirst%3DM.%2BP.%26aulast%3DLowe%26aufirst%3DA.%2BM.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DShipp%26aufirst%3DM.%2BA.%26atitle%3DInhibition%2520of%2520Syk%2520with%2520fostamatinib%2520disodium%2520has%2520significant%2520clinical%2520activity%2520in%2520non-Hodgkin%2520lymphoma%2520and%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2578%26epage%3D2585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikranian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Torres, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straniero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Gonzales, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E.</span><span> </span><span class="NLM_article-title">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">â</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1002%2Fart.23992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=18975322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3309-3318&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=R.+Burgos-Vargasauthor=A.+H.+Dikranianauthor=G.+Medrano-Ramirezauthor=J.+L.+Morales-Torresauthor=F.+T.+Murphyauthor=T.+K.+Musserauthor=N.+Stranieroauthor=A.+V.+Vicente-Gonzalesauthor=E.+Grossbard&title=Treatment+of+rheumatoid+arthritis+with+a+Syk+kinase+inhibitor%3A+a+twelve-week%2C+randomized%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Burgos-Vargas, Ruben; Dikranian, Ara H.; Medrano-Ramirez, Gabriel; Morales-Torres, Jorge L.; Murphy, Frederick T.; Musser, Theresa Kane; Straniero, Nicholas; Vicente-Gonzales, Angela V.; Grossbard, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing FcÎ³-activating receptors.  R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro and in vivo models, suggesting potential activity in the treatment of rheumatoid arthritis (RA).  Methods: We enrolled 189 patients with active RA despite methotrexate therapy in a 3-mo, multicenter, ascending-dose, double-blind, placebo-controlled trial.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results: Twice-daily oral doses of 100 mg and 150 mg of R788 were significantly superior to placebo or twice-daily oral doses of 50 mg at week 12 (ACR20 achieved in 65% and 72% vs. 38% and 32% of patients, resp. [P < 0.01]).  ACR50 (achieved in 49% and 57% vs. 19% and 17% of patients, resp.) and ACR70 (achieved in 33% and 40% vs. 4% and 2% of patients, resp.) scores showed a similar pattern.  Clin. effect was noted as early as 1 wk after initiation of therapy.  Redns. in serum interleukin-6 and matrix metalloproteinase 3 levels also occurred as early as week 1 in the groups receiving 100 mg and 150 mg R788.  The major adverse effects were gastrointestinal side effects (predominantly diarrhea) and neutropenia (<1,500/mm3), both of which were dose related.  Conclusion: These results indicate that an inhibitor of Syk kinase produces significant clin. benefits at 12 wk in a population of patients with active RA receiving methotrexate therapy.  Syk kinase may be an important new therapeutic target in RA and related autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqomUu-KV6uvbVg90H21EOLACvtfcHk0lioGMXzL7sgyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF&md5=a49db998eb1a011d8ae59580f4c868c6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fart.23992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23992%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDikranian%26aufirst%3DA.%2BH.%26aulast%3DMedrano-Ramirez%26aufirst%3DG.%26aulast%3DMorales-Torres%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DF.%2BT.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DStraniero%26aufirst%3DN.%26aulast%3DVicente-Gonzales%26aufirst%3DA.%2BV.%26aulast%3DGrossbard%26aufirst%3DE.%26atitle%3DTreatment%2520of%2520rheumatoid%2520arthritis%2520with%2520a%2520Syk%2520kinase%2520inhibitor%253A%2520a%2520twelve-week%252C%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3309%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">A hypothesis for the rational design of highly selective spleen tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10414</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301367c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10414&author=M.+C.+Lucasauthor=D.+Goldsteinauthor=J.+C.+Hermannauthor=A.+Kuglstatterauthor=C.+Liaoauthor=W.+Liuauthor=K.-C.+Lukauthor=F.+Padillaauthor=J.+Wannerauthor=W.+Xieauthor=J.+Zhang&title=A+hypothesis+for+the+rational+design+of+highly+selective+spleen+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm301367c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301367c%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLuk%26aufirst%3DK.-C.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DA%2520hypothesis%2520for%2520the%2520rational%2520design%2520of%2520highly%2520selective%2520spleen%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Padilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagirath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy-Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowrie, L. E.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O-Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfeld, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VillaseÃ±or, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Ce.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span> </span><span class="NLM_article-title">Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301720p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1677&author=F.+Padillaauthor=N.+Bhagirathauthor=S.+Chenauthor=E.+Chiaoauthor=D.+M.+Goldsteinauthor=J.+C.+Hermannauthor=J.+Hsuauthor=J.+J.+Kennedy-Smithauthor=A.+Kuglstatterauthor=C.+Liaoauthor=W.+Liuauthor=L.+E.+Lowrieauthor=K.-C.+Lukauthor=S.+M.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=T.+Owensauthor=C.+O-Yangauthor=A.+Railkarauthor=R.+C.+Schoenfeldauthor=M.+Sladeauthor=S.+Steinerauthor=Y.-C.+Tanauthor=A.+G.+Villase%C3%B1orauthor=Ce.+Wangauthor=J.+Wannerauthor=W.+Xieauthor=D.+Xuauthor=X.+Zhangauthor=M.+Zhouauthor=M.+C.+Lucas&title=Pyrrolopyrazines+as+selective+spleen+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm301720p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301720p%26sid%3Dliteratum%253Aachs%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DBhagirath%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChiao%26aufirst%3DE.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DKennedy-Smith%26aufirst%3DJ.%2BJ.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLowrie%26aufirst%3DL.%2BE.%26aulast%3DLuk%26aufirst%3DK.-C.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DOwens%26aufirst%3DT.%26aulast%3DO-Yang%26aufirst%3DC.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DY.-C.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DCe.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26atitle%3DPyrrolopyrazines%2520as%2520selective%2520spleen%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pashine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.-L.</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">R146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liao%2C+C.%3B+Hsu%2C+J.%3B+Kim%2C+Y.%3B+Hu%2C+D.-Q.%3B+Xu%2C+D.%3B+Zhang%2C+J.%3B+Pashine%2C+A.%3B+Menke%2C+J.%3B+Whittard%2C+T.%3B+Romero%2C+N.%3B+Truitt%2C+T.%3B+Slade%2C+M.%3B+Lukacs%2C+C.%3B+Hermann%2C+J.%3B+Zhou%2C+M.%3B+Lucas%2C+M.%3B+Narula%2C+S.%3B+DeMartino%2C+J.%3B+Tan%2C+S.-L.Arthritis+Res.+Ther.+2013%2C+15%2C+R146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DD.-Q.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPashine%26aufirst%3DA.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DWhittard%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DN.%26aulast%3DTruitt%26aufirst%3DT.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DHermann%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DM.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DDeMartino%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DS.-L.%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2013%26volume%3D15%26spage%3DR146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Maron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B. N.</span><span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">â</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0lgSlY1FGHc_Lw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">VillaseÃ±or, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">â</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1111%2Fj.1747-0285.2009.00785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=19220318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2009&pages=466-470&author=A.+G.+Villase%C3%B1orauthor=R.+Kondruauthor=H.+Hoauthor=S.+Wangauthor=E.+Pappauthor=D.+Shawauthor=J.+W.+Barnettauthor=M.+F.+Brownerauthor=A.+Kuglstatter&title=Structural+insights+for+design+of+potent+spleen+tyrosine+kinase+inhibitors+from+crystallographic+analysis+of+three+inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span></div><div class="casAuthors">Villasenor, Armando G.; Kondru, Rama; Ho, Hoangdung; Wang, Sandra; Papp, Eva; Shaw, David; Barnett, Jim W.; Browner, Michelle F.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase is considered an attractive drug target for the treatment of allergic and anti-body mediated autoimmune diseases.  We have detd. the co-crystal structures of spleen tyrosine kinase complexed with three known inhibitors: YM193306, a 7-azaindole deriv. and R406.  The cis-cyclohexyldiamino moiety of YM193306 is forming four hydrophobically shielded polar interactions with the spleen tyrosine kinase protein and is therefore crucial for the high potency of this inhibitor.  Its primary amino group is inducing a conformational change of the spleen tyrosine kinase DFG Asp side chain.  The crystal structure of the 7-azaindole deriv. bound to spleen tyrosine kinase is the first demonstration of a 2-substituted 7-azaindole bound to a protein kinase.  Its indole-amide substituent is tightly packed between the N- and C-terminal kinase lobes.  The co-crystal structure of the spleen tyrosine kinase-R406 complex shows two main differences to the previously reported structure of spleen tyrosine kinase soaked with R406: (i) the side chain of the highly conserved Lys is disordered and not forming a hydrogen bond to R406 and (ii) the DFG Asp side chain is pointing away from and not towards R406.  The novel protein-ligand interactions and protein conformational changes revealed in these structures guide the rational design and structure-based optimization of second-generation spleen tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ofv25cSrSbVg90H21EOLACvtfcHk0liC8CWD4VZ2oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D&md5=1646c908ca57dc3b1d612769f9a53c02</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00785.x%26sid%3Dliteratum%253Aachs%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DBarnett%26aufirst%3DJ.%2BW.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DStructural%2520insights%2520for%2520design%2520of%2520potent%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520from%2520crystallographic%2520analysis%2520of%2520three%2520inhibitor%2520complexes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D73%26spage%3D466%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zimmer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazurek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhuyan, B. K.</span><span> </span><span class="NLM_article-title">Bacterial mutagenicity and mammalian cell DNA damage by several substituted anilines</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1016%2F0165-1218%2880%2990003-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=6990249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADyaL3cXkt1SntLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1980&pages=317-326&author=D.+Zimmerauthor=J.+Mazurekauthor=G.+Petzoldauthor=B.+K.+Bhuyan&title=Bacterial+mutagenicity+and+mammalian+cell+DNA+damage+by+several+substituted+anilines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial mutagenicity and mammalian cell DNA damage by several substituted anilines</span></div><div class="casAuthors">Zimmer, D.; Mazurek, J.; Petzold, G.; Bhuyan, B. K.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology Testing</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-26</span>CODEN:
                <span class="NLM_cas:coden">MRGTE4</span>;
        ISSN:<span class="NLM_cas:issn">0165-1218</span>.
    </div><div class="casAbstract">Several substituted alkyl- and haloanilines were tested for their ability to mutate Salmonella typhimurium and to damage the DNA of mammalian (V-79) cells.  These results were correlated with their reported carcinogenicity.  Of 9 suspected carcinogens, 4 were bacterial mutagens and 4 (out of 7 tested) damaged DNA of V-79 cells.  The following compds. were weakly mutagenic (<150 revertants/Î¼mole): 4-fluoroaniline (I)  [371-40-4], 2,3-dimethyl-  [87-59-2], 2,4-dimethyl-  [95-68-1], 2,5-dimethyl-  [95-78-3], and 3,4-dimethylaniline  [95-64-7], and 2-methyl-4-fluoroaniline  [452-71-1].  The following compds. were strong mutagens: 2,4,5-trimethylaniline  [137-17-7], 2-methyl-4-chloro-  [95-69-2], 2-methyl-4-bromo-  [583-75-5], 4-methyl-2-chloro-  [615-65-6], 4-methyl-2-bromo-  [583-68-6], and 2-ethyl-4-chloroaniline  [30273-39-3].  The compds. which damaged DNA in V-79 cells were: 2-methyl-4-chloroaniline, 2-methyl-4-bromoaniline, 2,4,5- and 2,4,6-trimethylaniline  [88-05-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQLDHNd6DtsrVg90H21EOLACvtfcHk0liC8CWD4VZ2oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkt1SntLs%253D&md5=46336de407eba5df7ad7dd8fb9610131</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0165-1218%2880%2990003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1218%252880%252990003-8%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DD.%26aulast%3DMazurek%26aufirst%3DJ.%26aulast%3DPetzold%26aufirst%3DG.%26aulast%3DBhuyan%26aufirst%3DB.%2BK.%26atitle%3DBacterial%2520mutagenicity%2520and%2520mammalian%2520cell%2520DNA%2520damage%2520by%2520several%2520substituted%2520anilines%26jtitle%3DMutat.%2520Res.%26date%3D1980%26volume%3D77%26spage%3D317%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">The 30 kinase panel included the following: tyrosine kinases: ALK, BTK, EPHB1, ITK, JAK1, JAK3, KDR, LCK, LYNa, MET, PDGFRÎ², SYK, ZAP70; serine/threonine kinases: AKT3, AurC, CaMK2a, CK1Î´ (CSNK1d), CLK1, CLK2, DYRK1B, Erk2 (MAPK1), GSK3Î², NEK7, p38Î±, p70S6K (S6K1, RPS6KB1), PAK4, PEK (EIF2AK2, PRKR), PIM2, ROCK1; and other kinases: PIK3CA. All kinases were tested at a single inhibitor concentration, in the presence of ATP, in duplicate, and percent inhibition was measured. The assay was performed at Carna Biosciences, Inc.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Alex, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between â¼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0liC8CWD4VZ2oA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Beckford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. W.</span><span> </span><span class="NLM_article-title">Molecular dynamics of anthraquinone DNA intercalators with polyethylene glycol side chains</span> <span class="citation_source-journal">J. Biomol. Struct. Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">â</span> <span class="NLM_lpage">1080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1080%2F073911012010525031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22292960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVSitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=1065-1080&author=S.+J.+Beckfordauthor=D.+W.+Dixon&title=Molecular+dynamics+of+anthraquinone+DNA+intercalators+with+polyethylene+glycol+side+chains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics of anthraquinone DNA intercalators with polyethylene glycol side chains</span></div><div class="casAuthors">Beckford, Shirlene Jackson; Dixon, Dabney W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1065-1080</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Adenine Press</span>)
        </div><div class="casAbstract">The interactions of a homologous series of four anthraquinone (AQ) intercalators with increasing lengths of polyethylene glycol (PEG) side chains with DNA have been studied via mol. dynamics (MD) simulations.  The geometry, conformation, interactions, and hydration of the complexes were examd.  The geometries of the four ligands were similar with parallel stacking to the long axis of the adjacent DNA base pairs.  Hydrogen bonding between the AQ amide and DNA led to a preference for the trans-syn conformer.  As the side chain lengthened, binding to DNA reduced the conformational space, resulting in an increase in unfavorable entropy.  Increased localization of the PEG side chain in the DNA groove, indicating some interaction of the side chain with DNA, also contributed unfavorably to the entropy.  The changes in free energy of binding due to entropic considerations (-3.9 to -6.3 kcal/mol) of AQ I-IV were significant.  The hydration of the PEG side chain decreased upon binding to DNA.  Understanding of side chain conformations, interactions, and hydration changes that accompany the formation of a ligand-DNA complex may be important in the development of new applications of pegylated small mols. that target biol. macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI7i5R_nUi5bVg90H21EOLACvtfcHk0ljVKHBxH3qbwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVSitL8%253D&md5=1e87b378ff401a898150817c8d015a78</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F073911012010525031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F073911012010525031%26sid%3Dliteratum%253Aachs%26aulast%3DBeckford%26aufirst%3DS.%2BJ.%26aulast%3DDixon%26aufirst%3DD.%2BW.%26atitle%3DMolecular%2520dynamics%2520of%2520anthraquinone%2520DNA%2520intercalators%2520with%2520polyethylene%2520glycol%2520side%2520chains%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2012%26volume%3D29%26spage%3D1065%26epage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">Ovality is defined as the ratio of the molecular surface area to the minimum surface area. The minimum surface area is the surface area of a sphere having a volume equal to the solvent-excluded volume of the molecule (computed from the Connolly molecular surface area and solvent-excluded volume properties).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KeserÃ¼, G. M.</span><span> </span><span class="NLM_article-title">Finding the sweet spot: The role of nature and nurture in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">â</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1038%2Fnrd3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22543468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=355-364&author=M.+M.+Hannauthor=G.+M.+Keser%C3%BC&title=Finding+the+sweet+spot%3A+The+role+of+nature+and+nurture+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Finding the sweet spot: the role of nature and nurture in medicinal chemistry</span></div><div class="casAuthors">Hann, Michael M.; Keserue, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Given its position at the heart of small-mol. drug discovery, medicinal chem. has an important role in tackling the well-known productivity challenges in pharmaceutical research and development.  In recent years, extensive analyses of successful and failed discovery compds. and drug candidates have improved our understanding of the role of physicochem. properties in drug attrition.  Based on the clarified challenges in finding the 'sweet spot' in medicinal chem. programs, we suggest that this goal can be achieved through a combination of first identifying chem. starting points with appropriate 'nature' and then rigorously 'nurturing' them during lead optimization.  Here, we discuss scientific, strategic, organizational and cultural considerations for medicinal chem. practices, with the aim of promoting more effective use of what is already known, as well as a wider appreciation of the risks of pursuing suboptimal compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURciGjB2A3LVg90H21EOLACvtfcHk0ljVKHBxH3qbwg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D&md5=90170e3f4e69e52bfa38667df380516a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrd3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3701%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DFinding%2520the%2520sweet%2520spot%253A%2520The%2520role%2520of%2520nature%2520and%2520nurture%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postelnek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pashine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâMahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span> </span><span class="NLM_article-title">RN486, a selective Brutonâs tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1124%2Fjpet.111.187740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22228807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A280%3ADC%252BC38zhtFymtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=90-103&author=D.+Xuauthor=Y.+Kimauthor=J.+Postelnekauthor=M.+D.+Vuauthor=D.+Q.+Huauthor=C.+Liaoauthor=M.+Bradshawauthor=J.+Hsuauthor=J.+Zhangauthor=A.+Pashineauthor=D.+Srinivasanauthor=J.+Woodsauthor=A.+Levinauthor=A.+O%E2%80%99Mahonyauthor=T.+D.+Owensauthor=Y.+Louauthor=R.+J.+Hillauthor=S.+Narulaauthor=J.+DeMartinoauthor=J.+S.+Fine&title=RN486%2C+a+selective+Bruton%E2%80%99s+tyrosine+kinase+inhibitor%2C+abrogates+immune+hypersensitivity+responses+and+arthritis+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents</span></div><div class="casAuthors">Xu Daigen; Kim Yong; Postelnek Jennifer; Vu Minh Diem; Hu Dong-Qing; Liao Cheng; Bradshaw Mike; Hsu Jonathan; Zhang Jun; Pashine Achal; Srinivasan Dinesh; Woods John; Levin Anita; O'Mahony Alison; Owens Timothy D; Lou Yan; Hill Ronald J; Narula Satwant; Demartino Julie; Fine Jay S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Genetic mutation and pharmacological inhibition of Bruton's tyrosine kinase (Btk) both have been shown to prevent the development of collagen-induced arthritis (CIA) in mice, providing a rationale for the development of Btk inhibitors for treating rheumatoid arthritis (RA).  In the present study, we characterized a novel Btk inhibitor, 6-cyclopropyl-8-fluoro-2-(2-hydroxymethyl-3-{1-methyl-5-[5-(4-methyl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-2H-isoquinolin-1-one (RN486), in vitro and in rodent models of immune hypersensitivity and arthritis.  We demonstrated that RN486 not only potently and selectively inhibited the Btk enzyme, but also displayed functional activities in human cell-based assays in multiple cell types, blocking FcÎµ receptor cross-linking-induced degranulation in mast cells (IC(50) = 2.9 nM), FcÎ³ receptor engagement-mediated tumor necrosis factor Î± production in monocytes (IC(50) = 7.0 nM), and B cell antigen receptor-induced expression of an activation marker, CD69, in B cells in whole blood (IC(50) = 21.0 nM).  RN486 displayed similar functional activities in rodent models, effectively preventing type I and type III hypersensitivity responses.  More importantly, RN486 produced robust anti-inflammatory and bone-protective effects in mouse CIA and rat adjuvant-induced arthritis (AIA) models.  In the AIA model, RN486 inhibited both joint and systemic inflammation either alone or in combination with methotrexate, reducing both paw swelling and inflammatory markers in the blood.  Together, our findings not only demonstrate that Btk plays an essential and conserved role in regulating immunoreceptor-mediated immune responses in both humans and rodents, but also provide evidence and mechanistic insights to support the development of selective Btk inhibitors as small-molecule disease-modifying drugs for RA and potentially other autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqSnPYc5dDCNj_Vg2vObihfW6udTcc2eZvqmysr-a5dbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zhtFymtQ%253D%253D&md5=a04c33939073dc33beda20c4b5e833d3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.187740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.187740%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPostelnek%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DM.%2BD.%26aulast%3DHu%26aufirst%3DD.%2BQ.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DBradshaw%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPashine%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DD.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DLevin%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DDeMartino%26aufirst%3DJ.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26atitle%3DRN486%252C%2520a%2520selective%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520inhibitor%252C%2520abrogates%2520immune%2520hypersensitivity%2520responses%2520and%2520arthritis%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D90%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':[],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':[],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Peter Blomgren, Jayaraman Chandrasekhar, Julie A. Di Paolo, Wanchi Fung, Guoju Geng, Carmen Ip, Randall Jones, Jeffrey E. Kropf, Eric B. Lansdon, Seung Lee, Jennifer R. Lo, Scott A. Mitchell, Bernard Murray, Chris Pohlmeyer, Aaron Schmitt, Kimberly Suekawa-Pirrone, Sarah Wise, Jin-Ming Xiong, Jianjun Xu, Helen Yu, Zhongdong Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Kevin S. Currie</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 506-513. <a href="https://doi.org/10.1021/acsmedchemlett.9b00621" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00621%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BLanraplenib%252B%252528GS-9876%252529%25253A%252BA%252BOnce-Daily%252BSpleen%252BTyrosine%252BKinase%252BInhibitor%252Bfor%252BAutoimmune%252BDiseases%26aulast%3DBlomgren%26aufirst%3DPeter%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18122019%26date%3D12022020%26date%3D13022020%26date%3D12022020%26volume%3D11%26issue%3D4%26spage%3D506%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Menghao Zhao, Xia Li, Jiaan Shao, Wenteng Chen, Ning Xie, Hu Yuan, Qingyan Sun, <span class="NLM_string-name hlFld-ContribAuthor">Weidong Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Pyrimidopyrrolopyridazines via a Tandem Reaction of Heterocyclic Ketene Aminals with 1,2-Diaza-1,3-dienes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (10)
                                     , 3057-3060. <a href="https://doi.org/10.1021/acs.orglett.8b01094" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01094%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BPyrimidopyrrolopyridazines%252Bvia%252Ba%252BTandem%252BReaction%252Bof%252BHeterocyclic%252BKetene%252BAminals%252Bwith%252B1%25252C2-Diaza-1%25252C3-dienes%26aulast%3DZhao%26aufirst%3DMenghao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07042018%26date%3D30042018%26volume%3D20%26issue%3D10%26spage%3D3057%26epage%3D3060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Michael  Ellis</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Brandon  Cash</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Haidle</span>, <span class="hlFld-ContribAuthor ">Rachel L.  Kubiak</span>, <span class="hlFld-ContribAuthor ">Matthew L.  Maddess</span>, <span class="hlFld-ContribAuthor ">Youwei  Yan</span>, and <span class="hlFld-ContribAuthor ">Alan B.  Northrup</span>  . </span><span class="cited-content_cbyCitation_article-title">Carboxamide Spleen Tyrosine Kinase (Syk) Inhibitors: Leveraging Ground State Interactions To Accelerate Optimization. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (12)
                                     , 1151-1155. <a href="https://doi.org/10.1021/acsmedchemlett.6b00353" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00353%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCarboxamide%252BSpleen%252BTyrosine%252BKinase%252B%252528Syk%252529%252BInhibitors%25253A%252BLeveraging%252BGround%252BState%252BInteractions%252BTo%252BAccelerate%252BOptimization%26aulast%3DEllis%26aufirst%3DJ.%2BMichael%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05092016%26date%3D07102016%26date%3D17102016%26date%3D08122016%26date%3D07102016%26volume%3D7%26issue%3D12%26spage%3D1151%26epage%3D1155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Ai</span>, <span class="hlFld-ContribAuthor ">Yang  Hu</span>, <span class="hlFld-ContribAuthor ">Fenghua  Kang</span>, <span class="hlFld-ContribAuthor ">Yisheng  Lai</span>, <span class="hlFld-ContribAuthor ">Yanju  Jia</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Sixun  Peng</span>, <span class="hlFld-ContribAuthor ">Hui  Ji</span>, <span class="hlFld-ContribAuthor ">Jide  Tian</span>, and <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Olean-28,13Î²-lactams as Potential Antiprostate Cancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4506-4520. <a href="https://doi.org/10.1021/jm5020023" title="DOI URL">https://doi.org/10.1021/jm5020023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5020023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5020023%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BOlean-28%25252C13%2525CE%2525B2-lactams%252Bas%252BPotential%252BAntiprostate%252BCancer%252BAgents%26aulast%3DAi%26aufirst%3DYong%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D24122014%26date%3D02062015%26date%3D11062015%26date%3D20052015%26volume%3D58%26issue%3D11%26spage%3D4506%26epage%3D4520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Michael  Ellis</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Alan  Bass</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">Alan J.  Byford</span>, <span class="hlFld-ContribAuthor ">Anthony  Donofrio</span>, <span class="hlFld-ContribAuthor ">Sheila  Galloway</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Haidle</span>, <span class="hlFld-ContribAuthor ">James  Jewell</span>, <span class="hlFld-ContribAuthor ">Nancy  Kelly</span>, <span class="hlFld-ContribAuthor ">Erica K.  Leccese</span>, <span class="hlFld-ContribAuthor ">Sandra  Lee</span>, <span class="hlFld-ContribAuthor ">Matthew  Maddess</span>, <span class="hlFld-ContribAuthor ">J. Richard  Miller</span>, <span class="hlFld-ContribAuthor ">Lily Y.  Moy</span>, <span class="hlFld-ContribAuthor ">Ekundayo  Osimboni</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Otte</span>, <span class="hlFld-ContribAuthor ">M. Vijay  Reddy</span>, <span class="hlFld-ContribAuthor ">Kerrie  Spencer</span>, <span class="hlFld-ContribAuthor ">Binyuan  Sun</span>, <span class="hlFld-ContribAuthor ">Stella H.  Vincent</span>, <span class="hlFld-ContribAuthor ">Gwendolyn J.  Ward</span>, <span class="hlFld-ContribAuthor ">Grace H. C.  Woo</span>, <span class="hlFld-ContribAuthor ">Chiming  Yang</span>, <span class="hlFld-ContribAuthor ">Hani  Houshyar</span>, and <span class="hlFld-ContribAuthor ">Alan B.  Northrup</span>  . </span><span class="cited-content_cbyCitation_article-title">Overcoming Mutagenicity and Ion Channel Activity: Optimization of Selective Spleen Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (4)
                                     , 1929-1939. <a href="https://doi.org/10.1021/jm5018169" title="DOI URL">https://doi.org/10.1021/jm5018169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5018169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5018169%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOvercoming%252BMutagenicity%252Band%252BIon%252BChannel%252BActivity%25253A%252BOptimization%252Bof%252BSelective%252BSpleen%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DEllis%26aufirst%3DJ.%2BMichael%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D24112014%26date%3D16022015%26date%3D26022015%26date%3D27012015%26volume%3D58%26issue%3D4%26spage%3D1929%26epage%3D1939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gebhard  Thoma</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Smith</span>, <span class="hlFld-ContribAuthor ">Maurice J.  van Eis</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Joachim  Blanz</span>, <span class="hlFld-ContribAuthor ">Reiner  Aichholz</span>, <span class="hlFld-ContribAuthor ">Amanda  Littlewood-Evans</span>, <span class="hlFld-ContribAuthor ">Christian C.  Lee</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, and <span class="hlFld-ContribAuthor ">Hans-GÃ¼nter  Zerwes</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Profiling of a Selective and Efficacious Syk Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (4)
                                     , 1950-1963. <a href="https://doi.org/10.1021/jm5018863" title="DOI URL">https://doi.org/10.1021/jm5018863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5018863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5018863%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BProfiling%252Bof%252Ba%252BSelective%252Band%252BEfficacious%252BSyk%252BInhibitor%26aulast%3DThoma%26aufirst%3DGebhard%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D09022015%26date%3D26022015%26date%3D29012015%26volume%3D58%26issue%3D4%26spage%3D1950%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Che  Tung</span>, <span class="hlFld-ContribAuthor ">Keng-Chang  Tsai</span>, <span class="hlFld-ContribAuthor ">Kit-Man  Fung</span>, <span class="hlFld-ContribAuthor ">Ming-Jaw  Don</span>, <span class="hlFld-ContribAuthor ">Tien-Sheng  Tseng</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the structureâactivity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 2453-2461. <a href="https://doi.org/10.1039/D0RA08769F" title="DOI URL">https://doi.org/10.1039/D0RA08769F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA08769F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA08769F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCharacterizing%252Bthe%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnatural%252Bproducts%25252C%252Btanshinones%25252C%252Breveals%252Btheir%252Bmode%252Bof%252Baction%252Bin%252Binhibiting%252Bspleen%252Btyrosine%252Bkinase%26aulast%3DTung%26aufirst%3DMin-Che%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D2453%26epage%3D2461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Chinigo</span>, <span class="hlFld-ContribAuthor ">Yiqing  Feng</span>, <span class="hlFld-ContribAuthor ">Susan  Hoy</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Matthew  Perry</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00082-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00082-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00082-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00082-2%26sid%3Dliteratum%253Aachs%26atitle%3DPyridazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DChinigo%26aufirst%3DGary%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhadhang Wahyu  Kurniawan</span>, <span class="hlFld-ContribAuthor ">Gert  Storm</span>, <span class="hlFld-ContribAuthor ">Jai  Prakash</span>, <span class="hlFld-ContribAuthor ">Ruchi  Bansal</span>. </span><span class="cited-content_cbyCitation_article-title">Role of spleen tyrosine kinase in liver diseases. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2020,</strong> <em>26 </em>
                                    (10)
                                     , 1005-1019. <a href="https://doi.org/10.3748/wjg.v26.i10.1005" title="DOI URL">https://doi.org/10.3748/wjg.v26.i10.1005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v26.i10.1005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v26.i10.1005%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DRole%252Bof%252Bspleen%252Btyrosine%252Bkinase%252Bin%252Bliver%252Bdiseases%26aulast%3DKurniawan%26aufirst%3DDhadhang%2BWahyu%26date%3D2020%26volume%3D26%26issue%3D10%26spage%3D1005%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inul  Ansary</span>, <span class="hlFld-ContribAuthor ">Hiren  Roy</span>, <span class="hlFld-ContribAuthor ">Arijit  Das</span>, <span class="hlFld-ContribAuthor ">Debanjan  Mitra</span>, <span class="hlFld-ContribAuthor ">Amal Kumar  Bandyopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis,Â Molecular Descriptors ofÂ (1,5âDisubstituted 1,2,3âTriazolyl)Coumarin/Quinolone Derivatives and Their Docking Studies against Cancer Targets. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (12)
                                     , 3486-3494. <a href="https://doi.org/10.1002/slct.201900114" title="DOI URL">https://doi.org/10.1002/slct.201900114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201900114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201900114%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DRegioselective%252BSynthesis%25252C%2525C2%2525A0Molecular%252BDescriptors%252Bof%2525C2%2525A0%2525281%25252C5%2525E2%252580%252590Disubstituted%252B1%25252C2%25252C3%2525E2%252580%252590Triazolyl%252529Coumarin%25252FQuinolone%252BDerivatives%252Band%252BTheir%252BDocking%252BStudies%252Bagainst%252BCancer%252BTargets%26aulast%3DAnsary%26aufirst%3DInul%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D12%26spage%3D3486%26epage%3D3494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing  Wang</span>, <span class="hlFld-ContribAuthor ">Junfang  Guo</span>, <span class="hlFld-ContribAuthor ">Zhongqi  Ning</span>, <span class="hlFld-ContribAuthor ">Xia  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Natural Syk Inhibitor from Chinese Medicine through a Docking-Based Virtual Screening and Biological Assay Study. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3114. <a href="https://doi.org/10.3390/molecules23123114" title="DOI URL">https://doi.org/10.3390/molecules23123114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123114%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252Ba%252BNatural%252BSyk%252BInhibitor%252Bfrom%252BChinese%252BMedicine%252Bthrough%252Ba%252BDocking-Based%252BVirtual%252BScreening%252Band%252BBiological%252BAssay%252BStudy%26aulast%3DWang%26aufirst%3DXing%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Mina-Osorio</span>. </span><span class="cited-content_cbyCitation_article-title">Review: Basics of Drug Development in Rheumatology. </span><span class="cited-content_cbyCitation_journal-name">Arthritis & Rheumatology</span><span> <strong>2015,</strong> <em>67 </em>
                                    (10)
                                     , 2581-2590. <a href="https://doi.org/10.1002/art.39253" title="DOI URL">https://doi.org/10.1002/art.39253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/art.39253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fart.39253%26sid%3Dliteratum%253Aachs%26jtitle%3DArthritis%2520%2526%2520Rheumatology%26atitle%3DReview%25253A%252BBasics%252Bof%252BDrug%252BDevelopment%252Bin%252BRheumatology%26aulast%3DMina-Osorio%26aufirst%3DPaola%26date%3D2015%26date%3D2015%26volume%3D67%26issue%3D10%26spage%3D2581%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gebhard  Thoma</span>, <span class="hlFld-ContribAuthor ">Siem  Veenstra</span>, <span class="hlFld-ContribAuthor ">Ross  Strang</span>, <span class="hlFld-ContribAuthor ">Joachim  Blanz</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">JÃ¶rg  Berghausen</span>, <span class="hlFld-ContribAuthor ">Christian C.  Lee</span>, <span class="hlFld-ContribAuthor ">Hans-GÃ¼nter  Zerwes</span>. </span><span class="cited-content_cbyCitation_article-title">Orally bioavailable Syk inhibitors with activity in a rat PK/PD model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4642-4647. <a href="https://doi.org/10.1016/j.bmcl.2015.08.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.08.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.08.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOrally%252Bbioavailable%252BSyk%252Binhibitors%252Bwith%252Bactivity%252Bin%252Ba%252Brat%252BPK%25252FPD%252Bmodel%26aulast%3DThoma%26aufirst%3DGebhard%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4642%26epage%3D4647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingling  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Liyan  Miao</span>, <span class="hlFld-ContribAuthor ">Lixin  Huang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Benzylidene Derivatives as Potent Syk Inhibitors: Synthesis, SAR Analysis, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (7)
                                     , 463-474. <a href="https://doi.org/10.1002/ardp.201500096" title="DOI URL">https://doi.org/10.1002/ardp.201500096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201500096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201500096%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDiscovery%252Bof%252BBenzylidene%252BDerivatives%252Bas%252BPotent%252BSyk%252BInhibitors%25253A%252BSynthesis%25252C%252BSAR%252BAnalysis%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DZhang%26aufirst%3DLingling%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D7%26spage%3D463%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C  Lucas</span>, <span class="hlFld-ContribAuthor ">Seng-Lai  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (16)
                                     , 1811-1827. <a href="https://doi.org/10.4155/fmc.14.126" title="DOI URL">https://doi.org/10.4155/fmc.14.126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.126%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall-molecule%252Binhibitors%252Bof%252Bspleen%252Btyrosine%252Bkinase%252Bas%252Btherapeutic%252Bagents%252Bfor%252Bimmune%252Bdisorders%25253A%252Bwill%252Bpromise%252Bmeet%252Bexpectations%25253F%26aulast%3DLucas%26aufirst%3DMatthew%2BC%26date%3D2014%26volume%3D6%26issue%3D16%26spage%3D1811%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Fostamatinib (<b>1</b>), PRT-062607 (<b>2</b>), and GSK-143 (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of Roche selective Syk inhibitors <b>4</b>â<b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyridazines <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) 2-aminopyridine, acetonitrile, 80 Â°C; (b) 7 N ammonia in methanol, rt; (c) R<sup>3</sup>-NH<sub>2</sub>, NMP, 140 Â°C.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of <b>14</b> bound to Syk.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Flat molecules are known to be DNA intercalators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Clinical scores from the assessment of <b>19</b> in the mouse collagen-induced arthritis model. Collagen-induced arthritis was induced in young adult male DBA1/J mice (7â8 weeks of age) as described previously by immunizing them twice with bovine type II collagen.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Test compound was administered orally once a day for 14 days starting the day after the second immunization. Arthritis was monitored by observing redness and swelling of the paws or digits and given a clinical score based on a scale of 0â4 per paw with 4 being the most severe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Average ovality and relationship to mutagenicity. Ovality was measured based on the fragment shown. 74% of compounds mutagenic if ovality <1.44, while 67% of compounds nonmutagenic or inconclusive had ovality >1.44.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/medium/jm-2013-01982j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Plot of ovality, clogP, and Ames mutagenicity result (No = not mutagenic in any of the five strains tested; Yes = mutagenic in at least one of the five strains tested; Inconclusive = number of reverting colonies just exceeded threshold of 2-fold increase over control). Properties describing a hypothetical âsafe zoneâ is depicted as a green oval.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401982j/production/images/large/jm-2013-01982j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401982j&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i17">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Mocsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase: A crucial player in diverse biological functions</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1038%2Fnri2765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=20467426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=387-402&author=A.+Mocsaiauthor=J.+Rulandauthor=V.+L.+J.+Tybulewicz&title=The+SYK+tyrosine+kinase%3A+A+crucial+player+in+diverse+biological+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The SYK tyrosine kinase: a crucial player in diverse biological functions</span></div><div class="casAuthors">Mocsai, Attila; Ruland, Jurgen; Tybulewicz, Victor L. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">387-402</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (SYK) is known to have a crucial role in adaptive immune receptor signalling.  However, recent reports indicate that SYK also mediates other, unexpectedly diverse biol. functions, including cellular adhesion, innate immune recognition, osteoclast maturation, platelet activation and vascular development.  SYK is activated by C-type lectins and integrins, and activates new targets, including the CARD9-BCL-10-MALT1 pathway and the NLRP3 inflammasome.  Studies using Drosophila melanogaster suggest that there is an evolutionarily ancient origin of SYK-mediated signalling.  Moreover, SYK has a crucial role in autoimmune diseases and haematol. malignancies.  This Review summarizes our current understanding of the diverse functions of SYK and how this is being translated for therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3YO5BcMqrf7Vg90H21EOLACvtfcHk0ljBuKZQZ6delw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D&md5=85857a2b9beb84e0fe74263a90fa8a53</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri2765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2765%26sid%3Dliteratum%253Aachs%26aulast%3DMocsai%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%253A%2520A%2520crucial%2520player%2520in%2520diverse%2520biological%2520functions%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D387%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bajpai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase: A novel target for therapeutic intervention of rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">â</span> <span class="NLM_lpage">659</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=641-659&author=M.+Bajpaiauthor=P.+Chopraauthor=S.+G.+Dastidarauthor=A.+Ray&title=Spleen+tyrosine+kinase%3A+A+novel+target+for+therapeutic+intervention+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBajpai%26aufirst%3DM.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DDastidar%26aufirst%3DS.%2BG.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DSpleen%2520tyrosine%2520kinase%253A%2520A%2520novel%2520target%2520for%2520therapeutic%2520intervention%2520of%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D641%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Zou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shattil, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span> </span><span class="NLM_article-title">Syk, c-Src, the Î±vÎ²3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">â</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2007&pages=877-888&author=W.+Zouauthor=H.+Kitauraauthor=J.+Reeveauthor=F.+Longauthor=V.+L.+Tybulewiczauthor=S.+J.+Shattilauthor=M.+H.+Ginsbergauthor=F.+P.+Rossauthor=S.+L.+Teitelbaum&title=Syk%2C+c-Src%2C+the+%CE%B1v%CE%B23+integrin%2C+and+ITAM+immunoreceptors%2C+in+concert%2C+regulate+osteoclastic+bone+resorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DW.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DReeve%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26aulast%3DShattil%26aufirst%3DS.%2BJ.%26aulast%3DGinsberg%26aufirst%3DM.%2BH.%26aulast%3DRoss%26aufirst%3DF.%2BP.%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26atitle%3DSyk%252C%2520c-Src%252C%2520the%2520%25CE%25B1v%25CE%25B23%2520integrin%252C%2520and%2520ITAM%2520immunoreceptors%252C%2520in%2520concert%252C%2520regulate%2520osteoclastic%2520bone%2520resorption%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D176%26spage%3D877%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Koga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suematsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, T.</span><span> </span><span class="NLM_article-title">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">â</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1038%2Fnature02444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=15085135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=758-763&author=T.+Kogaauthor=M.+Inuiauthor=K.+Inoueauthor=S.+Kimauthor=A.+Suematsuauthor=E.+Kobayashiauthor=T.+Iwataauthor=H.+Ohnishiauthor=T.+Matozakiauthor=T.+Kodamaauthor=T.+Taniguchiauthor=H.+Takayanagiauthor=T.+Takai&title=Costimulatory+signals+mediated+by+the+ITAM+motif+cooperate+with+RANKL+for+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span></div><div class="casAuthors">Koga, Takako; Inui, Masanori; Inoue, Kazuya; Kim, Sunhwa; Suematsu, Ayako; Kobayashi, Eiji; Iwata, Toshio; Ohnishi, Hiroshi; Matozaki, Takashi; Kodama, Tatsuhiko; Taniguchi, Tadatsugu; Takayanagi, Hiroshi; Takai, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6984</span>),
    <span class="NLM_cas:pages">758-763</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Costimulatory signals are required for activation of immune cells, but it is not known whether they contribute to other biol. systems.  The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption.  Receptor activator of NF-ÎºB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF).  But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis.  Here the authors show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)-harboring adaptors, Fc receptor common Î³ subunit (FcRÎ³) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation.  In osteoclast precursor cells, FcRÎ³ and DAP12 assoc. with multiple immunoreceptors and activate calcium signaling through phospholipase CÎ³.  Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis.  These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvHiH4e8xvSLVg90H21EOLACvtfcHk0liO3CZVLIhU-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D&md5=cc70a7455fe1d9932271758c2791eac5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature02444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02444%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSuematsu%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DE.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DH.%26aulast%3DMatozaki%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DH.%26aulast%3DTakai%26aufirst%3DT.%26atitle%3DCostimulatory%2520signals%2520mediated%2520by%2520the%2520ITAM%2520motif%2520cooperate%2520with%2520RANKL%2520for%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D758%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tam, F. W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAdoo, S. P.</span><span> </span><span class="NLM_article-title">Fostamatinib disodium</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1358%2Fdof.2011.036.04.1588554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=23284223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1ylurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=273-280&author=F.+W.+K.+Tamauthor=S.+P.+McAdoo&title=Fostamatinib+disodium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Fostamatinib disodium: tyrosine-protein kinase SYK/FLT3 inhibitor treatment of rheumatoid arthritis oncolytic</span></div><div class="casAuthors">McAdoo, S. P.; Tam, F. W. K.; Pandian, R.; Bolos, J.; Castaner, R.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-280</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The non-receptor tyrosine-protein kinase SYK (spleen tyrosine kinase) has a diverse range of biol. functions, including a crit. role in the intracellular signaling cascade for the surface Ig receptor on B lymphocytes and the Fc receptor expressed on numerous immune effector cells.  It is therefore seen as a potential therapeutic target in a variety of conditions, including autoimmune, allergic and malignant diseases.  Fostamatinib disodium is the orally bioavailable prodrug of R-406, a relatively selective small-mol. inhibitor of SYK, that has accordingly shown activity in numerous cell types in vitro, and efficacy in a remarkable range of animal models in vivo, including rodent models of asthma, inflammatory arthritis, lupus, glomerulonephritis, diabetes and lymphoma.  Success in these models has translated to phase II clin. trials in autoimmune thrombocytopenia, lymphoma and, most notably, rheumatoid arthritis, in which larger phase III trials are currently in progress.  While the diverse biol. functions of SYK coupled with the potential off-target effects of this kinase inhibitor are a source of possible toxicity, the available data thus far augur well for future clin. use of fostamatinib in a wide range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1UBbKHhezKrVg90H21EOLACvtfcHk0lgGtKnrMx994Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1ylurs%253D&md5=762da3b1321b7eadbe9ae531221b5593</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.04.1588554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.04.1588554%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DF.%2BW.%2BK.%26aulast%3DMcAdoo%26aufirst%3DS.%2BP.%26atitle%3DFostamatinib%2520disodium%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D273%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pandey, A.</span><span> </span><span class="NLM_article-title">Discovery of PRT062607: A potent and selective Syk inhibitor for the treatment of inflammatory, B cell proliferative diseases and thrombosis</span>. CHI 6th Annual Drug Discovery Chemistry Conference, San Diego, CA, April 12â13,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+Pandey&title=Discovery+of+PRT062607%3A+A+potent+and+selective+Syk+inhibitor+for+the+treatment+of+inflammatory%2C+B+cell+proliferative+diseases+and+thrombosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520PRT062607%253A%2520A%2520potent%2520and%2520selective%2520Syk%2520inhibitor%2520for%2520the%2520treatment%2520of%2520inflammatory%252C%2520B%2520cell%2520proliferative%2520diseases%2520and%2520thrombosis%26jtitle%3DCHI%25206th%2520Annual%2520Drug%2520Discovery%2520Chemistry%2520Conference%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Coffey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGuzman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ives, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbach, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, U.</span><span> </span><span class="NLM_article-title">Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">â</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1124%2Fjpet.111.188441" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=350-359&author=G.+Coffeyauthor=F.+DeGuzmanauthor=M.+Inagakiauthor=Y.+Pakauthor=S.+M.+Delaneyauthor=D.+Ivesauthor=A.+Betzauthor=Z.+J.+Jiaauthor=A.+Pandeyauthor=D.+Bakerauthor=S.+J.+Hollenbachauthor=D.+R.+Phillipsauthor=U.+Sinha&title=Specific+inhibition+of+spleen+tyrosine+kinase+suppresses+leukocyte+immune+function+and+inflammation+in+animal+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.188441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.188441%26sid%3Dliteratum%253Aachs%26aulast%3DCoffey%26aufirst%3DG.%26aulast%3DDeGuzman%26aufirst%3DF.%26aulast%3DInagaki%26aufirst%3DM.%26aulast%3DPak%26aufirst%3DY.%26aulast%3DDelaney%26aufirst%3DS.%2BM.%26aulast%3DIves%26aufirst%3DD.%26aulast%3DBetz%26aufirst%3DA.%26aulast%3DJia%26aufirst%3DZ.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DHollenbach%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DD.%2BR.%26aulast%3DSinha%26aufirst%3DU.%26atitle%3DSpecific%2520inhibition%2520of%2520spleen%2520tyrosine%2520kinase%2520suppresses%2520leukocyte%2520immune%2520function%2520and%2520inflammation%2520in%2520animal%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D34%26spage%3D350%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gilead</span><span class="NLM_x">. Pipeline. </span><a href="http://www.gilead.com/pipeline" class="extLink">http://www.gilead.com/pipeline</a> (accessed February 2014).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gilead.+Pipeline.+http%3A%2F%2Fwww.gilead.com%2Fpipeline+%28accessed+February+2014%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elwes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garton, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhow, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, A. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez-Molina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weingarten, G. G.</span><span> </span><span class="NLM_article-title">Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6188</span><span class="NLM_x">â</span> <span class="NLM_lpage">6194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6188-6194&author=J.+Liddleauthor=F.+L.+Atkinsonauthor=M.+D.+Barkerauthor=P.+S.+Carterauthor=N.+R.+Curtisauthor=R.+P.+Davisauthor=C.+Douaultauthor=M.+C.+Dicksonauthor=D.+Elwesauthor=N.+S.+Gartonauthor=M.+Grayauthor=T.+G.+Hayhowauthor=C.+I.+Hobbsauthor=E.+Jonesauthor=S.+Leachauthor=K.+Leavensauthor=H.+D.+Lewisauthor=S.+McClearyauthor=M.+Neuauthor=V.+K.+Patelauthor=A.+G.+S.+Prestonauthor=C.+Ramirez-Molinaauthor=T.+J.+Shipleyauthor=P.+A.+Skoneauthor=N.+Smithersauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=R.+J.+Watsonauthor=G.+G.+Weingarten&title=Discovery+of+GSK143%2C+a+highly+potent%2C+selective+and+orally+efficacious+spleen+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DAtkinson%26aufirst%3DF.%2BL.%26aulast%3DBarker%26aufirst%3DM.%2BD.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DCurtis%26aufirst%3DN.%2BR.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DDouault%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DM.%2BC.%26aulast%3DElwes%26aufirst%3DD.%26aulast%3DGarton%26aufirst%3DN.%2BS.%26aulast%3DGray%26aufirst%3DM.%26aulast%3DHayhow%26aufirst%3DT.%2BG.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DS.%26aulast%3DLeavens%26aufirst%3DK.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DPreston%26aufirst%3DA.%2BG.%2BS.%26aulast%3DRamirez-Molina%26aufirst%3DC.%26aulast%3DShipley%26aufirst%3DT.%2BJ.%26aulast%3DSkone%26aufirst%3DP.%2BA.%26aulast%3DSmithers%26aufirst%3DN.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26aulast%3DWeingarten%26aufirst%3DG.%2BG.%26atitle%3DDiscovery%2520of%2520GSK143%252C%2520a%2520highly%2520potent%252C%2520selective%2520and%2520orally%2520efficacious%2520spleen%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6188%26epage%3D6194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Clemens, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magness, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lech, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span> <span class="citation_source-journal">Birth Defects Res., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">â</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1002%2Fbdra.20505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=19107952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=130-136&author=G.+R.+Clemensauthor=R.+E.+Schroederauthor=S.+H.+Magnessauthor=E.+V.+Weaverauthor=J.+W.+Lechauthor=V.+C.+Taylorauthor=E.+S.+Masudaauthor=M.+Baluomauthor=E.+B.+Grossbard&title=Developmental+toxicity+associated+with+receptor+tyrosine+kinase+Ret+inhibition+in+reproductive+toxicity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span></div><div class="casAuthors">Clemens, George R.; Schroeder, Raymond E.; Magness, Steven H.; Weaver, Elizabeth V.; Lech, Joseph W.; Taylor, Vanessa C.; Masuda, Esteban S.; Baluom, Muhammad; Grossbard, Elliott B.</div><div class="citationInfo"><span class="NLM_cas:title">Birth Defects Research, Part A: Clinical and Molecular Teratology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-136</span>CODEN:
                <span class="NLM_cas:coden">BDRPBT</span>;
        ISSN:<span class="NLM_cas:issn">1542-0752</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Urogenital abnormalities are among the most common of all human birth defects.  In developmental toxicity studies with the Syk kinase inhibitor R788, a spectrum of findings, including renal agenesis, were obsd.  R788 was also found to inhibit the receptor tyrosine kinase Ret.  Ret kinase is known to be an essential component in the signaling pathway required for renal organogenesis and ureteric duct formation.  Previously known is that mutant mice without the c-ret gene, develop urogenital malformations including renal agenesis.  In GLP developmental toxicity studies, gravid rabbits were treated orally with R788 at doses of 0, 10, 22, and 50 mg/kg/day (gestation days 7-19) and gravid rats received 0, 5, 12.5, and 25 mg/kg/day (gestation days 6-17) by the same route.  The activity of R406 against Ret kinase was assessed in biochem. and cell-based assays.  A dose-dependent increase in malformations, including renal and ureteric agenesis and a specific major vessel anomaly, retro-esophageal right subclavian artery, was obsd. in both the rat and rabbit.  R788 proved to be a potent inhibitor of Ret kinase.  R788 promoted a spectrum of developmental toxicity, including renal and ureteric agenesis and a specific major vessel abnormality, retro-esophageal right subclavian artery, in 2 different species.  These effects are likely the result of inhibition of Ret kinase given its importance in the normal ontogeny of the urogenital and cardiovascular systems across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkk1lYWlmwebVg90H21EOLACvtfcHk0lg89NNRP0csjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D&md5=9cd3909537d2d22ce666d1e0e426ec7c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fbdra.20505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdra.20505%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DG.%2BR.%26aulast%3DSchroeder%26aufirst%3DR.%2BE.%26aulast%3DMagness%26aufirst%3DS.%2BH.%26aulast%3DWeaver%26aufirst%3DE.%2BV.%26aulast%3DLech%26aufirst%3DJ.%2BW.%26aulast%3DTaylor%26aufirst%3DV.%2BC.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DDevelopmental%2520toxicity%2520associated%2520with%2520receptor%2520tyrosine%2520kinase%2520Ret%2520inhibition%2520in%2520reproductive%2520toxicity%2520testing%26jtitle%3DBirth%2520Defects%2520Res.%252C%2520Part%2520A%26date%3D2009%26volume%3D85%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Friedberg, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetenham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vose, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacasce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer-Cutillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cripe, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterba, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipp, M. A.</span><span> </span><span class="NLM_article-title">Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2578</span><span class="NLM_x">â</span> <span class="NLM_lpage">2585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2578-2585&author=J.+W.+Friedbergauthor=J.+Sharmanauthor=J.+Sweetenhamauthor=P.+B.+Johnstonauthor=J.+M.+Voseauthor=A.+Lacasceauthor=J.+Schaefer-Cutilloauthor=S.+De+Vosauthor=R.+Sinhaauthor=J.+P.+Leonardauthor=L.+D.+Cripeauthor=S.+A.+Gregoryauthor=M.+P.+Sterbaauthor=A.+M.+Loweauthor=R.+Levyauthor=M.+A.+Shipp&title=Inhibition+of+Syk+with+fostamatinib+disodium+has+significant+clinical+activity+in+non-Hodgkin+lymphoma+and+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedberg%26aufirst%3DJ.%2BW.%26aulast%3DSharman%26aufirst%3DJ.%26aulast%3DSweetenham%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DP.%2BB.%26aulast%3DVose%26aufirst%3DJ.%2BM.%26aulast%3DLacasce%26aufirst%3DA.%26aulast%3DSchaefer-Cutillo%26aufirst%3DJ.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DJ.%2BP.%26aulast%3DCripe%26aufirst%3DL.%2BD.%26aulast%3DGregory%26aufirst%3DS.%2BA.%26aulast%3DSterba%26aufirst%3DM.%2BP.%26aulast%3DLowe%26aufirst%3DA.%2BM.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DShipp%26aufirst%3DM.%2BA.%26atitle%3DInhibition%2520of%2520Syk%2520with%2520fostamatinib%2520disodium%2520has%2520significant%2520clinical%2520activity%2520in%2520non-Hodgkin%2520lymphoma%2520and%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2578%26epage%3D2585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikranian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Torres, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straniero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Gonzales, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E.</span><span> </span><span class="NLM_article-title">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">â</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1002%2Fart.23992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=18975322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3309-3318&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=R.+Burgos-Vargasauthor=A.+H.+Dikranianauthor=G.+Medrano-Ramirezauthor=J.+L.+Morales-Torresauthor=F.+T.+Murphyauthor=T.+K.+Musserauthor=N.+Stranieroauthor=A.+V.+Vicente-Gonzalesauthor=E.+Grossbard&title=Treatment+of+rheumatoid+arthritis+with+a+Syk+kinase+inhibitor%3A+a+twelve-week%2C+randomized%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Burgos-Vargas, Ruben; Dikranian, Ara H.; Medrano-Ramirez, Gabriel; Morales-Torres, Jorge L.; Murphy, Frederick T.; Musser, Theresa Kane; Straniero, Nicholas; Vicente-Gonzales, Angela V.; Grossbard, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing FcÎ³-activating receptors.  R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro and in vivo models, suggesting potential activity in the treatment of rheumatoid arthritis (RA).  Methods: We enrolled 189 patients with active RA despite methotrexate therapy in a 3-mo, multicenter, ascending-dose, double-blind, placebo-controlled trial.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results: Twice-daily oral doses of 100 mg and 150 mg of R788 were significantly superior to placebo or twice-daily oral doses of 50 mg at week 12 (ACR20 achieved in 65% and 72% vs. 38% and 32% of patients, resp. [P < 0.01]).  ACR50 (achieved in 49% and 57% vs. 19% and 17% of patients, resp.) and ACR70 (achieved in 33% and 40% vs. 4% and 2% of patients, resp.) scores showed a similar pattern.  Clin. effect was noted as early as 1 wk after initiation of therapy.  Redns. in serum interleukin-6 and matrix metalloproteinase 3 levels also occurred as early as week 1 in the groups receiving 100 mg and 150 mg R788.  The major adverse effects were gastrointestinal side effects (predominantly diarrhea) and neutropenia (<1,500/mm3), both of which were dose related.  Conclusion: These results indicate that an inhibitor of Syk kinase produces significant clin. benefits at 12 wk in a population of patients with active RA receiving methotrexate therapy.  Syk kinase may be an important new therapeutic target in RA and related autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqomUu-KV6uvbVg90H21EOLACvtfcHk0lg89NNRP0csjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF&md5=a49db998eb1a011d8ae59580f4c868c6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fart.23992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23992%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDikranian%26aufirst%3DA.%2BH.%26aulast%3DMedrano-Ramirez%26aufirst%3DG.%26aulast%3DMorales-Torres%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DF.%2BT.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DStraniero%26aufirst%3DN.%26aulast%3DVicente-Gonzales%26aufirst%3DA.%2BV.%26aulast%3DGrossbard%26aufirst%3DE.%26atitle%3DTreatment%2520of%2520rheumatoid%2520arthritis%2520with%2520a%2520Syk%2520kinase%2520inhibitor%253A%2520a%2520twelve-week%252C%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3309%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">A hypothesis for the rational design of highly selective spleen tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10414</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301367c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10414&author=M.+C.+Lucasauthor=D.+Goldsteinauthor=J.+C.+Hermannauthor=A.+Kuglstatterauthor=C.+Liaoauthor=W.+Liuauthor=K.-C.+Lukauthor=F.+Padillaauthor=J.+Wannerauthor=W.+Xieauthor=J.+Zhang&title=A+hypothesis+for+the+rational+design+of+highly+selective+spleen+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm301367c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301367c%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLuk%26aufirst%3DK.-C.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DA%2520hypothesis%2520for%2520the%2520rational%2520design%2520of%2520highly%2520selective%2520spleen%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Padilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagirath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy-Smith, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowrie, L. E.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O-Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Railkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfeld, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VillaseÃ±or, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Ce.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span> </span><span class="NLM_article-title">Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301720p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1677&author=F.+Padillaauthor=N.+Bhagirathauthor=S.+Chenauthor=E.+Chiaoauthor=D.+M.+Goldsteinauthor=J.+C.+Hermannauthor=J.+Hsuauthor=J.+J.+Kennedy-Smithauthor=A.+Kuglstatterauthor=C.+Liaoauthor=W.+Liuauthor=L.+E.+Lowrieauthor=K.-C.+Lukauthor=S.+M.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=T.+Owensauthor=C.+O-Yangauthor=A.+Railkarauthor=R.+C.+Schoenfeldauthor=M.+Sladeauthor=S.+Steinerauthor=Y.-C.+Tanauthor=A.+G.+Villase%C3%B1orauthor=Ce.+Wangauthor=J.+Wannerauthor=W.+Xieauthor=D.+Xuauthor=X.+Zhangauthor=M.+Zhouauthor=M.+C.+Lucas&title=Pyrrolopyrazines+as+selective+spleen+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm301720p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301720p%26sid%3Dliteratum%253Aachs%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DBhagirath%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChiao%26aufirst%3DE.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DKennedy-Smith%26aufirst%3DJ.%2BJ.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLowrie%26aufirst%3DL.%2BE.%26aulast%3DLuk%26aufirst%3DK.-C.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DOwens%26aufirst%3DT.%26aulast%3DO-Yang%26aufirst%3DC.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DY.-C.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DCe.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26atitle%3DPyrrolopyrazines%2520as%2520selective%2520spleen%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pashine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.-L.</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">R146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liao%2C+C.%3B+Hsu%2C+J.%3B+Kim%2C+Y.%3B+Hu%2C+D.-Q.%3B+Xu%2C+D.%3B+Zhang%2C+J.%3B+Pashine%2C+A.%3B+Menke%2C+J.%3B+Whittard%2C+T.%3B+Romero%2C+N.%3B+Truitt%2C+T.%3B+Slade%2C+M.%3B+Lukacs%2C+C.%3B+Hermann%2C+J.%3B+Zhou%2C+M.%3B+Lucas%2C+M.%3B+Narula%2C+S.%3B+DeMartino%2C+J.%3B+Tan%2C+S.-L.Arthritis+Res.+Ther.+2013%2C+15%2C+R146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DD.-Q.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPashine%26aufirst%3DA.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DWhittard%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DN.%26aulast%3DTruitt%26aufirst%3DT.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DHermann%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DM.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DDeMartino%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DS.-L.%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2013%26volume%3D15%26spage%3DR146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Maron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B. N.</span><span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">â</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0ljS6ovNK0EfjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">VillaseÃ±or, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">â</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1111%2Fj.1747-0285.2009.00785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=19220318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2009&pages=466-470&author=A.+G.+Villase%C3%B1orauthor=R.+Kondruauthor=H.+Hoauthor=S.+Wangauthor=E.+Pappauthor=D.+Shawauthor=J.+W.+Barnettauthor=M.+F.+Brownerauthor=A.+Kuglstatter&title=Structural+insights+for+design+of+potent+spleen+tyrosine+kinase+inhibitors+from+crystallographic+analysis+of+three+inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span></div><div class="casAuthors">Villasenor, Armando G.; Kondru, Rama; Ho, Hoangdung; Wang, Sandra; Papp, Eva; Shaw, David; Barnett, Jim W.; Browner, Michelle F.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase is considered an attractive drug target for the treatment of allergic and anti-body mediated autoimmune diseases.  We have detd. the co-crystal structures of spleen tyrosine kinase complexed with three known inhibitors: YM193306, a 7-azaindole deriv. and R406.  The cis-cyclohexyldiamino moiety of YM193306 is forming four hydrophobically shielded polar interactions with the spleen tyrosine kinase protein and is therefore crucial for the high potency of this inhibitor.  Its primary amino group is inducing a conformational change of the spleen tyrosine kinase DFG Asp side chain.  The crystal structure of the 7-azaindole deriv. bound to spleen tyrosine kinase is the first demonstration of a 2-substituted 7-azaindole bound to a protein kinase.  Its indole-amide substituent is tightly packed between the N- and C-terminal kinase lobes.  The co-crystal structure of the spleen tyrosine kinase-R406 complex shows two main differences to the previously reported structure of spleen tyrosine kinase soaked with R406: (i) the side chain of the highly conserved Lys is disordered and not forming a hydrogen bond to R406 and (ii) the DFG Asp side chain is pointing away from and not towards R406.  The novel protein-ligand interactions and protein conformational changes revealed in these structures guide the rational design and structure-based optimization of second-generation spleen tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ofv25cSrSbVg90H21EOLACvtfcHk0ljS6ovNK0EfjA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D&md5=1646c908ca57dc3b1d612769f9a53c02</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00785.x%26sid%3Dliteratum%253Aachs%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DBarnett%26aufirst%3DJ.%2BW.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DStructural%2520insights%2520for%2520design%2520of%2520potent%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520from%2520crystallographic%2520analysis%2520of%2520three%2520inhibitor%2520complexes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D73%26spage%3D466%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zimmer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazurek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhuyan, B. K.</span><span> </span><span class="NLM_article-title">Bacterial mutagenicity and mammalian cell DNA damage by several substituted anilines</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1016%2F0165-1218%2880%2990003-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=6990249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADyaL3cXkt1SntLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1980&pages=317-326&author=D.+Zimmerauthor=J.+Mazurekauthor=G.+Petzoldauthor=B.+K.+Bhuyan&title=Bacterial+mutagenicity+and+mammalian+cell+DNA+damage+by+several+substituted+anilines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial mutagenicity and mammalian cell DNA damage by several substituted anilines</span></div><div class="casAuthors">Zimmer, D.; Mazurek, J.; Petzold, G.; Bhuyan, B. K.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Genetic Toxicology Testing</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-26</span>CODEN:
                <span class="NLM_cas:coden">MRGTE4</span>;
        ISSN:<span class="NLM_cas:issn">0165-1218</span>.
    </div><div class="casAbstract">Several substituted alkyl- and haloanilines were tested for their ability to mutate Salmonella typhimurium and to damage the DNA of mammalian (V-79) cells.  These results were correlated with their reported carcinogenicity.  Of 9 suspected carcinogens, 4 were bacterial mutagens and 4 (out of 7 tested) damaged DNA of V-79 cells.  The following compds. were weakly mutagenic (<150 revertants/Î¼mole): 4-fluoroaniline (I)  [371-40-4], 2,3-dimethyl-  [87-59-2], 2,4-dimethyl-  [95-68-1], 2,5-dimethyl-  [95-78-3], and 3,4-dimethylaniline  [95-64-7], and 2-methyl-4-fluoroaniline  [452-71-1].  The following compds. were strong mutagens: 2,4,5-trimethylaniline  [137-17-7], 2-methyl-4-chloro-  [95-69-2], 2-methyl-4-bromo-  [583-75-5], 4-methyl-2-chloro-  [615-65-6], 4-methyl-2-bromo-  [583-68-6], and 2-ethyl-4-chloroaniline  [30273-39-3].  The compds. which damaged DNA in V-79 cells were: 2-methyl-4-chloroaniline, 2-methyl-4-bromoaniline, 2,4,5- and 2,4,6-trimethylaniline  [88-05-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQLDHNd6DtsrVg90H21EOLACvtfcHk0ljdyU9uwYvjnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkt1SntLs%253D&md5=46336de407eba5df7ad7dd8fb9610131</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0165-1218%2880%2990003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1218%252880%252990003-8%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DD.%26aulast%3DMazurek%26aufirst%3DJ.%26aulast%3DPetzold%26aufirst%3DG.%26aulast%3DBhuyan%26aufirst%3DB.%2BK.%26atitle%3DBacterial%2520mutagenicity%2520and%2520mammalian%2520cell%2520DNA%2520damage%2520by%2520several%2520substituted%2520anilines%26jtitle%3DMutat.%2520Res.%26date%3D1980%26volume%3D77%26spage%3D317%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">The 30 kinase panel included the following: tyrosine kinases: ALK, BTK, EPHB1, ITK, JAK1, JAK3, KDR, LCK, LYNa, MET, PDGFRÎ², SYK, ZAP70; serine/threonine kinases: AKT3, AurC, CaMK2a, CK1Î´ (CSNK1d), CLK1, CLK2, DYRK1B, Erk2 (MAPK1), GSK3Î², NEK7, p38Î±, p70S6K (S6K1, RPS6KB1), PAK4, PEK (EIF2AK2, PRKR), PIM2, ROCK1; and other kinases: PIK3CA. All kinases were tested at a single inhibitor concentration, in the presence of ATP, in duplicate, and percent inhibition was measured. The assay was performed at Carna Biosciences, Inc.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Alex, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">â</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between â¼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0ljdyU9uwYvjnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Beckford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. W.</span><span> </span><span class="NLM_article-title">Molecular dynamics of anthraquinone DNA intercalators with polyethylene glycol side chains</span> <span class="citation_source-journal">J. Biomol. Struct. Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">â</span> <span class="NLM_lpage">1080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1080%2F073911012010525031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22292960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVSitL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=1065-1080&author=S.+J.+Beckfordauthor=D.+W.+Dixon&title=Molecular+dynamics+of+anthraquinone+DNA+intercalators+with+polyethylene+glycol+side+chains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics of anthraquinone DNA intercalators with polyethylene glycol side chains</span></div><div class="casAuthors">Beckford, Shirlene Jackson; Dixon, Dabney W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Structure and Dynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1065-1080</span>CODEN:
                <span class="NLM_cas:coden">JBSDD6</span>;
        ISSN:<span class="NLM_cas:issn">0739-1102</span>.
    
            (<span class="NLM_cas:orgname">Adenine Press</span>)
        </div><div class="casAbstract">The interactions of a homologous series of four anthraquinone (AQ) intercalators with increasing lengths of polyethylene glycol (PEG) side chains with DNA have been studied via mol. dynamics (MD) simulations.  The geometry, conformation, interactions, and hydration of the complexes were examd.  The geometries of the four ligands were similar with parallel stacking to the long axis of the adjacent DNA base pairs.  Hydrogen bonding between the AQ amide and DNA led to a preference for the trans-syn conformer.  As the side chain lengthened, binding to DNA reduced the conformational space, resulting in an increase in unfavorable entropy.  Increased localization of the PEG side chain in the DNA groove, indicating some interaction of the side chain with DNA, also contributed unfavorably to the entropy.  The changes in free energy of binding due to entropic considerations (-3.9 to -6.3 kcal/mol) of AQ I-IV were significant.  The hydration of the PEG side chain decreased upon binding to DNA.  Understanding of side chain conformations, interactions, and hydration changes that accompany the formation of a ligand-DNA complex may be important in the development of new applications of pegylated small mols. that target biol. macromols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI7i5R_nUi5bVg90H21EOLACvtfcHk0ljdyU9uwYvjnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVSitL8%253D&md5=1e87b378ff401a898150817c8d015a78</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1080%2F073911012010525031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F073911012010525031%26sid%3Dliteratum%253Aachs%26aulast%3DBeckford%26aufirst%3DS.%2BJ.%26aulast%3DDixon%26aufirst%3DD.%2BW.%26atitle%3DMolecular%2520dynamics%2520of%2520anthraquinone%2520DNA%2520intercalators%2520with%2520polyethylene%2520glycol%2520side%2520chains%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2012%26volume%3D29%26spage%3D1065%26epage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">Ovality is defined as the ratio of the molecular surface area to the minimum surface area. The minimum surface area is the surface area of a sphere having a volume equal to the solvent-excluded volume of the molecule (computed from the Connolly molecular surface area and solvent-excluded volume properties).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hann, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KeserÃ¼, G. M.</span><span> </span><span class="NLM_article-title">Finding the sweet spot: The role of nature and nurture in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">â</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1038%2Fnrd3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22543468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=355-364&author=M.+M.+Hannauthor=G.+M.+Keser%C3%BC&title=Finding+the+sweet+spot%3A+The+role+of+nature+and+nurture+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Finding the sweet spot: the role of nature and nurture in medicinal chemistry</span></div><div class="casAuthors">Hann, Michael M.; Keserue, Gyoergy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Given its position at the heart of small-mol. drug discovery, medicinal chem. has an important role in tackling the well-known productivity challenges in pharmaceutical research and development.  In recent years, extensive analyses of successful and failed discovery compds. and drug candidates have improved our understanding of the role of physicochem. properties in drug attrition.  Based on the clarified challenges in finding the 'sweet spot' in medicinal chem. programs, we suggest that this goal can be achieved through a combination of first identifying chem. starting points with appropriate 'nature' and then rigorously 'nurturing' them during lead optimization.  Here, we discuss scientific, strategic, organizational and cultural considerations for medicinal chem. practices, with the aim of promoting more effective use of what is already known, as well as a wider appreciation of the risks of pursuing suboptimal compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURciGjB2A3LVg90H21EOLACvtfcHk0ljxdLKl80-x7Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1GqsLY%253D&md5=90170e3f4e69e52bfa38667df380516a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnrd3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3701%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26atitle%3DFinding%2520the%2520sweet%2520spot%253A%2520The%2520role%2520of%2520nature%2520and%2520nurture%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postelnek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pashine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâMahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span> </span><span class="NLM_article-title">RN486, a selective Brutonâs tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401982j&amp;key=10.1124%2Fjpet.111.187740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401982j&amp;key=22228807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401982j&amp;key=1%3ACAS%3A280%3ADC%252BC38zhtFymtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=90-103&author=D.+Xuauthor=Y.+Kimauthor=J.+Postelnekauthor=M.+D.+Vuauthor=D.+Q.+Huauthor=C.+Liaoauthor=M.+Bradshawauthor=J.+Hsuauthor=J.+Zhangauthor=A.+Pashineauthor=D.+Srinivasanauthor=J.+Woodsauthor=A.+Levinauthor=A.+O%E2%80%99Mahonyauthor=T.+D.+Owensauthor=Y.+Louauthor=R.+J.+Hillauthor=S.+Narulaauthor=J.+DeMartinoauthor=J.+S.+Fine&title=RN486%2C+a+selective+Bruton%E2%80%99s+tyrosine+kinase+inhibitor%2C+abrogates+immune+hypersensitivity+responses+and+arthritis+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents</span></div><div class="casAuthors">Xu Daigen; Kim Yong; Postelnek Jennifer; Vu Minh Diem; Hu Dong-Qing; Liao Cheng; Bradshaw Mike; Hsu Jonathan; Zhang Jun; Pashine Achal; Srinivasan Dinesh; Woods John; Levin Anita; O'Mahony Alison; Owens Timothy D; Lou Yan; Hill Ronald J; Narula Satwant; Demartino Julie; Fine Jay S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">90-103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Genetic mutation and pharmacological inhibition of Bruton's tyrosine kinase (Btk) both have been shown to prevent the development of collagen-induced arthritis (CIA) in mice, providing a rationale for the development of Btk inhibitors for treating rheumatoid arthritis (RA).  In the present study, we characterized a novel Btk inhibitor, 6-cyclopropyl-8-fluoro-2-(2-hydroxymethyl-3-{1-methyl-5-[5-(4-methyl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-2H-isoquinolin-1-one (RN486), in vitro and in rodent models of immune hypersensitivity and arthritis.  We demonstrated that RN486 not only potently and selectively inhibited the Btk enzyme, but also displayed functional activities in human cell-based assays in multiple cell types, blocking FcÎµ receptor cross-linking-induced degranulation in mast cells (IC(50) = 2.9 nM), FcÎ³ receptor engagement-mediated tumor necrosis factor Î± production in monocytes (IC(50) = 7.0 nM), and B cell antigen receptor-induced expression of an activation marker, CD69, in B cells in whole blood (IC(50) = 21.0 nM).  RN486 displayed similar functional activities in rodent models, effectively preventing type I and type III hypersensitivity responses.  More importantly, RN486 produced robust anti-inflammatory and bone-protective effects in mouse CIA and rat adjuvant-induced arthritis (AIA) models.  In the AIA model, RN486 inhibited both joint and systemic inflammation either alone or in combination with methotrexate, reducing both paw swelling and inflammatory markers in the blood.  Together, our findings not only demonstrate that Btk plays an essential and conserved role in regulating immunoreceptor-mediated immune responses in both humans and rodents, but also provide evidence and mechanistic insights to support the development of selective Btk inhibitors as small-molecule disease-modifying drugs for RA and potentially other autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqSnPYc5dDCNj_Vg2vObihfW6udTcc2eYAUqVzqPqPL7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zhtFymtQ%253D%253D&md5=a04c33939073dc33beda20c4b5e833d3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.187740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.187740%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DPostelnek%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DM.%2BD.%26aulast%3DHu%26aufirst%3DD.%2BQ.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DBradshaw%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPashine%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DD.%26aulast%3DWoods%26aufirst%3DJ.%26aulast%3DLevin%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DHill%26aufirst%3DR.%2BJ.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DDeMartino%26aufirst%3DJ.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26atitle%3DRN486%252C%2520a%2520selective%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520inhibitor%252C%2520abrogates%2520immune%2520hypersensitivity%2520responses%2520and%2520arthritis%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D90%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i12"><a href="/doi/suppl/10.1021/jm401982j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48348"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for synthesis of final compounds and intermediates, and descriptions of assays performed. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401982j/suppl_file/jm401982j_si_001.pdf">jm401982j_si_001.pdf (729.12 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401982j&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-6%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm401982j%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401982j" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992149fc462483","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
